| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | MED15 NCOA3 NCOR2 NCOA6 TSC22D1 ARID1B KMT2D ATN1 BRD4 TOX3 ZMYND8 IRF2BPL MAML2 MIDEAS CREBBP MAML3 MED12 | 2.09e-14 | 562 | 51 | 17 | GO:0003712 |
| GeneOntologyMolecularFunction | transcription coactivator activity | NCOA3 NCOA6 TSC22D1 ARID1B KMT2D ATN1 BRD4 TOX3 MAML2 CREBBP MAML3 MED12 | 1.12e-11 | 303 | 51 | 12 | GO:0003713 |
| GeneOntologyMolecularFunction | chromatin binding | NCOA3 NCOR2 NCOA6 ARID1B ATXN1 ASCL1 POLG BRD4 TOX3 RUNX2 NFAT5 CREBBP MEF2A AR MED12 PHC1 | 2.26e-11 | 739 | 51 | 16 | GO:0003682 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | MED15 NCOA3 NCOR2 NCOA6 TSC22D1 ARID1B KMT2D ATN1 BRD4 TOX3 ZMYND8 IRF2BPL MAML2 MIDEAS CREBBP MAML3 AR MED12 | 2.23e-10 | 1160 | 51 | 18 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription factor binding | NCOA3 NCOR2 NCOA6 FOXP2 ASCL1 ZMYND8 ATXN3 RUNX2 NFAT5 CREBBP MEF2A AR MED12 HTT TBP | 3.48e-10 | 753 | 51 | 15 | GO:0008134 |
| GeneOntologyMolecularFunction | molecular adaptor activity | MED15 NCOA3 NCOR2 NCOA6 TSC22D1 ARID1B KMT2D ATN1 BRD4 TOX3 ZMYND8 IRF2BPL MAML2 MIDEAS CREBBP MAML3 AR MED12 | 2.73e-09 | 1356 | 51 | 18 | GO:0060090 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | NCOA3 NCOR2 NCOA6 FOXP2 ASCL1 ZMYND8 RUNX2 CREBBP MEF2A AR MED12 TBP | 1.89e-08 | 582 | 51 | 12 | GO:0140297 |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 7.06e-07 | 66 | 51 | 5 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 7.06e-07 | 66 | 51 | 5 | GO:0001098 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 9.70e-07 | 417 | 51 | 9 | GO:0061629 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | NCOA3 USF3 FOXP2 ASCL1 ATXN3 ZFHX3 RUNX2 ZNF853 NFAT5 CREBBP MEF2A AR MED12 TBP THAP11 | 2.17e-06 | 1459 | 51 | 15 | GO:0000977 |
| GeneOntologyMolecularFunction | nuclear receptor binding | 7.90e-06 | 187 | 51 | 6 | GO:0016922 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 2.02e-05 | 21 | 51 | 3 | GO:0042975 | |
| GeneOntologyMolecularFunction | general transcription initiation factor binding | 2.14e-05 | 64 | 51 | 4 | GO:0140296 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 2.49e-05 | 229 | 51 | 6 | GO:0003714 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor binding | 4.40e-05 | 27 | 51 | 3 | GO:0001091 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 8.01e-05 | 560 | 51 | 8 | GO:0001228 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 8.11e-05 | 33 | 51 | 3 | GO:0050681 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 8.63e-05 | 566 | 51 | 8 | GO:0001216 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 8.88e-05 | 34 | 51 | 3 | GO:0046966 | |
| GeneOntologyMolecularFunction | TFIIB-class transcription factor binding | 9.53e-05 | 6 | 51 | 2 | GO:0001093 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 1.15e-04 | 37 | 51 | 3 | GO:0043425 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | NCOA3 KMT2D USF3 FOXP2 ASCL1 ZFHX3 RUNX2 ZNF853 NFAT5 MEF2A AR THAP11 | 1.78e-04 | 1412 | 51 | 12 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | FOXP2 ASCL1 ZFHX3 RUNX2 ZNF853 NFAT5 MEF2A AR MED12 TBP THAP11 | 2.48e-04 | 1244 | 51 | 11 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | FOXP2 ASCL1 ZFHX3 RUNX2 ZNF853 NFAT5 MEF2A AR MED12 TBP THAP11 | 2.99e-04 | 1271 | 51 | 11 | GO:0000987 |
| GeneOntologyMolecularFunction | protein domain specific binding | 3.32e-04 | 875 | 51 | 9 | GO:0019904 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 4.48e-04 | 140 | 51 | 4 | GO:0001221 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 5.09e-04 | 61 | 51 | 3 | GO:0030374 | |
| GeneOntologyMolecularFunction | histone deacetylase binding | 5.39e-04 | 147 | 51 | 4 | GO:0042826 | |
| GeneOntologyMolecularFunction | nuclear vitamin D receptor binding | 9.53e-04 | 18 | 51 | 2 | GO:0042809 | |
| GeneOntologyMolecularFunction | p53 binding | 1.01e-03 | 77 | 51 | 3 | GO:0002039 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 1.18e-03 | 20 | 51 | 2 | GO:0035259 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 1.56e-03 | 23 | 51 | 2 | GO:0046965 | |
| GeneOntologyMolecularFunction | Notch binding | 2.16e-03 | 27 | 51 | 2 | GO:0005112 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 2.66e-03 | 30 | 51 | 2 | GO:0070577 | |
| GeneOntologyMolecularFunction | histone modifying activity | 2.76e-03 | 229 | 51 | 4 | GO:0140993 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 2.84e-03 | 31 | 51 | 2 | GO:0140033 | |
| GeneOntologyMolecularFunction | disordered domain specific binding | 4.46e-03 | 39 | 51 | 2 | GO:0097718 | |
| GeneOntologyMolecularFunction | RNA polymerase II complex binding | 4.46e-03 | 39 | 51 | 2 | GO:0000993 | |
| GeneOntologyMolecularFunction | chromatin-protein adaptor activity | 4.92e-03 | 41 | 51 | 2 | GO:0140463 | |
| GeneOntologyMolecularFunction | RNA polymerase core enzyme binding | 5.90e-03 | 45 | 51 | 2 | GO:0043175 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 7.53e-03 | 51 | 51 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 8.11e-03 | 53 | 51 | 2 | GO:0030331 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 8.41e-03 | 54 | 51 | 2 | GO:0001223 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 8.71e-03 | 55 | 51 | 2 | GO:0061733 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 8.71e-03 | 55 | 51 | 2 | GO:0042974 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 8.92e-03 | 167 | 51 | 3 | GO:0031490 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 8.95e-03 | 320 | 51 | 4 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 9.54e-03 | 326 | 51 | 4 | GO:0001217 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 1.03e-02 | 60 | 51 | 2 | GO:0034212 | |
| GeneOntologyMolecularFunction | RNA polymerase binding | 1.20e-02 | 65 | 51 | 2 | GO:0070063 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | MED15 NCOA3 NCOA6 TSC22D1 KMT2D USF3 ATXN1 ASCL1 BRD4 TOX3 ZMYND8 PAXIP1 IRF2BPL ZFHX3 MAML2 RUNX2 NFAT5 CREBBP MEF2A MAML3 AR MED12 TBP THAP11 | 2.49e-15 | 1390 | 51 | 24 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | NCOR2 ATN1 FOXP2 ATXN1 ASCL1 ZMYND8 IRF2BPL ZFHX3 RUNX2 MIDEAS CREBBP MEF2A AR PHC1 THAP11 | 8.55e-07 | 1399 | 51 | 15 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | NCOR2 ATN1 FOXP2 ATXN1 ASCL1 ZMYND8 IRF2BPL ZFHX3 RUNX2 MIDEAS CREBBP MEF2A AR PHC1 THAP11 | 9.70e-07 | 1413 | 51 | 15 | GO:1902679 |
| GeneOntologyBiologicalProcess | positive regulation of intracellular estrogen receptor signaling pathway | 3.08e-06 | 12 | 51 | 3 | GO:0033148 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | NCOR2 ATN1 FOXP2 ATXN1 ASCL1 ZMYND8 IRF2BPL ZFHX3 CREBBP MEF2A AR THAP11 | 7.36e-06 | 1053 | 51 | 12 | GO:0000122 |
| GeneOntologyBiologicalProcess | positive regulation of intracellular steroid hormone receptor signaling pathway | 1.13e-05 | 18 | 51 | 3 | GO:0033145 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 2.19e-05 | 231 | 51 | 6 | GO:0006352 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | MED15 NCOA3 ARID1B KMT2D BRD4 ZMYND8 PAXIP1 NFAT5 CREBBP PHC1 TBP | 2.61e-05 | 999 | 51 | 11 | GO:0071824 |
| GeneOntologyBiologicalProcess | positive regulation of transcription initiation by RNA polymerase II | 2.69e-05 | 70 | 51 | 4 | GO:0060261 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription initiation | 3.93e-05 | 77 | 51 | 4 | GO:2000144 | |
| GeneOntologyBiologicalProcess | subpallium development | 4.47e-05 | 28 | 51 | 3 | GO:0021544 | |
| GeneOntologyBiologicalProcess | regulation of transcription initiation by RNA polymerase II | 4.79e-05 | 81 | 51 | 4 | GO:0060260 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 6.34e-05 | 87 | 51 | 4 | GO:0033143 | |
| GeneOntologyBiologicalProcess | regulation of DNA-templated transcription initiation | 7.56e-05 | 91 | 51 | 4 | GO:2000142 | |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase II promoter | 9.48e-05 | 186 | 51 | 5 | GO:0006367 | |
| GeneOntologyBiologicalProcess | regulation of intracellular estrogen receptor signaling pathway | 9.60e-05 | 36 | 51 | 3 | GO:0033146 | |
| GeneOntologyBiologicalProcess | vocal learning | 1.25e-04 | 7 | 51 | 2 | GO:0042297 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription of Notch receptor target | 1.25e-04 | 7 | 51 | 2 | GO:0007221 | |
| GeneOntologyBiologicalProcess | imitative learning | 1.25e-04 | 7 | 51 | 2 | GO:0098596 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 1.40e-04 | 202 | 51 | 5 | GO:0141193 | |
| GeneOntologyBiologicalProcess | dendrite development | 1.71e-04 | 335 | 51 | 6 | GO:0016358 | |
| GeneOntologyBiologicalProcess | observational learning | 2.13e-04 | 9 | 51 | 2 | GO:0098597 | |
| GeneOntologyBiologicalProcess | development of secondary female sexual characteristics | 2.66e-04 | 10 | 51 | 2 | GO:0046543 | |
| GeneOntologyBiologicalProcess | chromatin organization | 3.11e-04 | 896 | 51 | 9 | GO:0006325 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription elongation by RNA polymerase II | 3.23e-04 | 54 | 51 | 3 | GO:0032968 | |
| GeneOntologyBiologicalProcess | determination of adult lifespan | 3.23e-04 | 54 | 51 | 3 | GO:0008340 | |
| GeneOntologyBiologicalProcess | learned vocalization behavior or vocal learning | 3.25e-04 | 11 | 51 | 2 | GO:0098598 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 3.35e-04 | 244 | 51 | 5 | GO:0009755 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 3.38e-04 | 906 | 51 | 9 | GO:0043009 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 3.55e-04 | 136 | 51 | 4 | GO:0030518 | |
| GeneOntologyBiologicalProcess | multicellular organism growth | 3.68e-04 | 249 | 51 | 5 | GO:0035264 | |
| GeneOntologyBiologicalProcess | head development | 3.75e-04 | 919 | 51 | 9 | GO:0060322 | |
| GeneOntologyBiologicalProcess | estrogen receptor signaling pathway | 3.79e-04 | 57 | 51 | 3 | GO:0030520 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 4.06e-04 | 929 | 51 | 9 | GO:0009792 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 4.33e-04 | 741 | 51 | 8 | GO:0006338 | |
| GeneOntologyBiologicalProcess | development of secondary sexual characteristics | 4.59e-04 | 13 | 51 | 2 | GO:0045136 | |
| GeneOntologyBiologicalProcess | lung epithelium development | 4.63e-04 | 61 | 51 | 3 | GO:0060428 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription, elongation | 4.86e-04 | 62 | 51 | 3 | GO:0032786 | |
| GeneOntologyBiologicalProcess | DNA damage response | 5.11e-04 | 959 | 51 | 9 | GO:0006974 | |
| GeneOntologyBiologicalProcess | auditory behavior | 5.35e-04 | 14 | 51 | 2 | GO:0031223 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 5.82e-04 | 155 | 51 | 4 | GO:0043401 | |
| GeneOntologyBiologicalProcess | central nervous system development | 6.02e-04 | 1197 | 51 | 10 | GO:0007417 | |
| GeneOntologyBiologicalProcess | embryo development | NCOA3 NCOR2 NCOA6 KMT2D FOXP2 BRD4 RUNX2 CREBBP AR MED12 HTT | 6.44e-04 | 1437 | 51 | 11 | GO:0009790 |
| GeneOntologyBiologicalProcess | mechanosensory behavior | 7.96e-04 | 17 | 51 | 2 | GO:0007638 | |
| GeneOntologyBiologicalProcess | maintenance of cell polarity | 1.11e-03 | 20 | 51 | 2 | GO:0030011 | |
| GeneOntologyBiologicalProcess | brain development | 1.14e-03 | 859 | 51 | 8 | GO:0007420 | |
| GeneOntologyBiologicalProcess | striatum development | 1.34e-03 | 22 | 51 | 2 | GO:0021756 | |
| GeneOntologyBiologicalProcess | telencephalon development | 1.34e-03 | 332 | 51 | 5 | GO:0021537 | |
| GeneOntologyCellularComponent | transcription regulator complex | MED15 NCOA3 NCOR2 NCOA6 ASCL1 ZFHX3 RUNX2 MIDEAS NFAT5 CREBBP MEF2A TBP THAP11 | 9.74e-10 | 596 | 50 | 13 | GO:0005667 |
| GeneOntologyCellularComponent | chromatin | NCOA3 NCOR2 ARID1B FOXP2 ASCL1 BRD4 ZMYND8 ZFHX3 RUNX2 NFAT5 CREBBP MEF2A AR PHC1 TBP THAP11 | 1.80e-07 | 1480 | 50 | 16 | GO:0000785 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | MED15 NCOA3 NCOR2 NCOA6 ARID1B KMT2D ASCL1 BRD4 PAXIP1 MIDEAS CREBBP MED12 PHC1 TBP THAP11 | 4.44e-07 | 1377 | 50 | 15 | GO:0140513 |
| GeneOntologyCellularComponent | MLL3/4 complex | 2.79e-06 | 12 | 50 | 3 | GO:0044666 | |
| GeneOntologyCellularComponent | nuclear matrix | 2.09e-05 | 140 | 50 | 5 | GO:0016363 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 4.51e-05 | 272 | 50 | 6 | GO:0090575 | |
| GeneOntologyCellularComponent | nuclear periphery | 5.43e-05 | 171 | 50 | 5 | GO:0034399 | |
| GeneOntologyCellularComponent | nuclear body | 2.56e-04 | 903 | 50 | 9 | GO:0016604 | |
| GeneOntologyCellularComponent | transferase complex | 4.11e-04 | 963 | 50 | 9 | GO:1990234 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 7.70e-04 | 75 | 50 | 3 | GO:0035097 | |
| GeneOntologyCellularComponent | nuclear cyclin-dependent protein kinase holoenzyme complex | 8.37e-04 | 18 | 50 | 2 | GO:0019908 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.04e-03 | 20 | 50 | 2 | GO:0042405 | |
| GeneOntologyCellularComponent | inclusion body | 1.31e-03 | 90 | 50 | 3 | GO:0016234 | |
| GeneOntologyCellularComponent | methyltransferase complex | 2.20e-03 | 108 | 50 | 3 | GO:0034708 | |
| HumanPheno | Prominent fingertip pads | 6.03e-08 | 46 | 25 | 6 | HP:0001212 | |
| HumanPheno | Prominent digit pad | 7.85e-08 | 48 | 25 | 6 | HP:0011298 | |
| HumanPheno | Progressive cerebellar ataxia | 4.55e-07 | 64 | 25 | 6 | HP:0002073 | |
| HumanPheno | Cerebellar ataxia | 6.56e-07 | 68 | 25 | 6 | HP:0001253 | |
| HumanPheno | Abnormal esophagus physiology | KMT2D ATN1 FOXP2 ATXN1 ASCL1 POLG BRD4 ATXN3 IRF2BPL CREBBP AR MED12 RAI1 HTT TBP | 4.10e-06 | 933 | 25 | 15 | HP:0025270 |
| HumanPheno | Abnormal esophagus morphology | KMT2D ATN1 FOXP2 ATXN1 ASCL1 POLG BRD4 MAMLD1 ATXN3 IRF2BPL CREBBP AR MED12 RAI1 HTT TBP | 4.24e-06 | 1078 | 25 | 16 | HP:0002031 |
| HumanPheno | Congenital diaphragmatic hernia | 6.45e-06 | 100 | 25 | 6 | HP:0000776 | |
| HumanPheno | Genetic anticipation | 8.61e-06 | 9 | 25 | 3 | HP:0003743 | |
| HumanPheno | Cleft palate | ARID1B KMT2D ATN1 FOXP2 BRD4 MAMLD1 KCNN3 RUNX2 CREBBP AR MED12 RAI1 | 1.61e-05 | 643 | 25 | 12 | HP:0000175 |
| HumanPheno | Abnormal hard palate morphology | ARID1B KMT2D ATN1 FOXP2 BRD4 MAMLD1 KCNN3 RUNX2 CREBBP AR MED12 RAI1 | 1.71e-05 | 647 | 25 | 12 | HP:0100737 |
| HumanPheno | Abnormality of the voice | 2.09e-05 | 545 | 25 | 11 | HP:0001608 | |
| HumanPheno | Aplasia/Hypoplasia of the distal phalanx of the 5th toe | 2.31e-05 | 2 | 25 | 2 | HP:0100371 | |
| HumanPheno | Ventral shortening of foreskin | 2.31e-05 | 2 | 25 | 2 | HP:0012435 | |
| HumanPheno | Abnormality of the distal phalanx of the 5th toe | 2.31e-05 | 2 | 25 | 2 | HP:0010392 | |
| HumanPheno | Abnormality of the larynx | ARID1B KMT2D FOXP2 POLG BRD4 ATXN3 CREBBP AR MED12 RAI1 HTT TBP | 2.31e-05 | 666 | 25 | 12 | HP:0001600 |
| HumanPheno | Abnormality of ocular smooth pursuit | 2.39e-05 | 74 | 25 | 5 | HP:0000617 | |
| HumanPheno | High palate | ARID1B KMT2D USF3 ATN1 FOXP2 BRD4 MAMLD1 KCNN3 SIK3 RUNX2 MN1 CREBBP MED12 | 2.44e-05 | 794 | 25 | 13 | HP:0000218 |
| HumanPheno | Orofacial cleft | ARID1B KMT2D ATN1 FOXP2 BRD4 MAMLD1 KCNN3 RUNX2 CREBBP AR MED12 RAI1 | 3.54e-05 | 694 | 25 | 12 | HP:0000202 |
| HumanPheno | Craniofacial cleft | ARID1B KMT2D ATN1 FOXP2 BRD4 MAMLD1 KCNN3 RUNX2 CREBBP AR MED12 RAI1 | 3.54e-05 | 694 | 25 | 12 | HP:5201015 |
| HumanPheno | Neuronal loss in central nervous system | 3.66e-05 | 40 | 25 | 4 | HP:0002529 | |
| HumanPheno | Abnormal prosody | 3.94e-05 | 82 | 25 | 5 | HP:0031434 | |
| HumanPheno | Functional abnormality of the gastrointestinal tract | ARID1B KMT2D ATN1 FOXP2 ATXN1 ASCL1 POLG BRD4 ATXN3 IRF2BPL CREBBP AR MED12 RAI1 HTT TBP | 3.96e-05 | 1270 | 25 | 16 | HP:0012719 |
| HumanPheno | Abnormality of the diaphragm | 4.64e-05 | 141 | 25 | 6 | HP:0000775 | |
| HumanPheno | Feeding difficulties | ARID1B KMT2D ATN1 FOXP2 ATXN1 POLG BRD4 ATXN3 IRF2BPL CREBBP AR RAI1 HTT TBP | 4.74e-05 | 982 | 25 | 14 | HP:0002022 |
| HumanPheno | Dysarthria | 6.17e-05 | 611 | 25 | 11 | HP:0001260 | |
| HumanPheno | Short phalanx of finger | 6.80e-05 | 306 | 25 | 8 | HP:0009803 | |
| HumanPheno | Limb ataxia | 6.88e-05 | 92 | 25 | 5 | HP:0002070 | |
| HumanPheno | Abnormality of proprioception | 8.49e-05 | 157 | 25 | 6 | HP:0010870 | |
| HumanPheno | Impaired proprioception | 8.49e-05 | 157 | 25 | 6 | HP:0010831 | |
| HumanPheno | Compulsive behaviors | 8.79e-05 | 158 | 25 | 6 | HP:0000722 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the hand | 9.15e-05 | 319 | 25 | 8 | HP:0009767 | |
| HumanPheno | Abnormal palate morphology | ARID1B KMT2D USF3 ATN1 FOXP2 BRD4 MAMLD1 KCNN3 SIK3 RUNX2 MN1 CREBBP AR MED12 RAI1 | 1.02e-04 | 1202 | 25 | 15 | HP:0000174 |
| HumanPheno | Short finger | 1.04e-04 | 325 | 25 | 8 | HP:0009381 | |
| HumanPheno | Deviation of finger | 1.17e-04 | 537 | 25 | 10 | HP:0004097 | |
| HumanPheno | Thin vermilion border | 1.27e-04 | 433 | 25 | 9 | HP:0000233 | |
| HumanPheno | Gaze-evoked nystagmus | 1.30e-04 | 55 | 25 | 4 | HP:0000640 | |
| HumanPheno | Aplasia/Hypoplasia of the 5th toe | 1.38e-04 | 4 | 25 | 2 | HP:0010343 | |
| HumanPheno | Expressive language delay | 1.40e-04 | 56 | 25 | 4 | HP:0002474 | |
| HumanPheno | Language delay | 1.40e-04 | 56 | 25 | 4 | HP:0002336 | |
| HumanPheno | Abnormality of the lower urinary tract | ARID1B KMT2D FOXP2 ATXN1 POLG BRD4 MAMLD1 ATXN3 CREBBP AR MED12 PHC1 TBP | 1.48e-04 | 937 | 25 | 13 | HP:0010936 |
| HumanPheno | Dysmetria | 1.76e-04 | 179 | 25 | 6 | HP:0001310 | |
| HumanPheno | Finger clinodactyly | 1.77e-04 | 452 | 25 | 9 | HP:0040019 | |
| HumanPheno | Deviation of the hand or of fingers of the hand | 1.78e-04 | 564 | 25 | 10 | HP:0009484 | |
| HumanPheno | Abnormal pitch | 1.83e-04 | 60 | 25 | 4 | HP:5200005 | |
| HumanPheno | Dysphagia | 1.86e-04 | 567 | 25 | 10 | HP:0002015 | |
| HumanPheno | Clinodactyly | 2.06e-04 | 574 | 25 | 10 | HP:0030084 | |
| HumanPheno | Bradykinesia | 2.07e-04 | 116 | 25 | 5 | HP:0002067 | |
| HumanPheno | Broad-based gait | 2.25e-04 | 118 | 25 | 5 | HP:0002136 | |
| HumanPheno | Blind vagina | 2.29e-04 | 5 | 25 | 2 | HP:0040314 | |
| HumanPheno | Supranuclear ophthalmoplegia | 2.29e-04 | 5 | 25 | 2 | HP:0000623 | |
| HumanPheno | Androgen insufficiency | 2.29e-04 | 5 | 25 | 2 | HP:0008226 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the 5th toe | 2.29e-04 | 5 | 25 | 2 | HP:0010383 | |
| HumanPheno | Abnormality of the phalanges of the 5th toe | 2.29e-04 | 5 | 25 | 2 | HP:0010342 | |
| HumanPheno | Short 5th finger | 2.35e-04 | 64 | 25 | 4 | HP:0009237 | |
| HumanPheno | Aplasia/Hypoplasia of fingers | 2.40e-04 | 366 | 25 | 8 | HP:0006265 | |
| HumanPheno | Functional abnormality of the bladder | 2.59e-04 | 590 | 25 | 10 | HP:0000009 | |
| HumanPheno | Aplasia/Hypoplasia of the 5th finger | 2.65e-04 | 66 | 25 | 4 | HP:0006262 | |
| HumanPheno | Abnormal Intonation | 3.15e-04 | 69 | 25 | 4 | HP:5200010 | |
| HumanPheno | Narrow palate | 3.40e-04 | 202 | 25 | 6 | HP:0000189 | |
| HumanPheno | Long eyelashes | 3.41e-04 | 129 | 25 | 5 | HP:0000527 | |
| HumanPheno | Urethral diverticulum | 3.43e-04 | 6 | 25 | 2 | HP:0008722 | |
| HumanPheno | Large foramen magnum | 3.43e-04 | 6 | 25 | 2 | HP:0002700 | |
| HumanPheno | Abnormal fingertip morphology | 3.49e-04 | 203 | 25 | 6 | HP:0001211 | |
| HumanPheno | Positive Romberg sign | 3.89e-04 | 30 | 25 | 3 | HP:0002403 | |
| HumanPheno | Abnormality of the bladder | 3.97e-04 | 621 | 25 | 10 | HP:0000014 | |
| HumanPheno | Sensory neuropathy | 3.99e-04 | 503 | 25 | 9 | HP:0000763 | |
| HumanPheno | Patent foramen ovale | 4.21e-04 | 135 | 25 | 5 | HP:0001655 | |
| HumanPheno | Weak voice | 4.29e-04 | 31 | 25 | 3 | HP:0001621 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the 5th finger | 4.72e-04 | 32 | 25 | 3 | HP:0009376 | |
| HumanPheno | Impaired horizontal smooth pursuit | 4.78e-04 | 7 | 25 | 2 | HP:0001151 | |
| HumanPheno | Delayed pubic bone ossification | 4.78e-04 | 7 | 25 | 2 | HP:0008788 | |
| HumanPheno | Truncal ataxia | 4.80e-04 | 77 | 25 | 4 | HP:0002078 | |
| HumanPheno | Gastroesophageal reflux | 4.91e-04 | 517 | 25 | 9 | HP:0002020 | |
| HumanPheno | Abnormal cerebral subcortex morphology | ARID1B KMT2D ATN1 FOXP2 POLG BRD4 ATXN3 IRF2BPL CREBBP MED12 RAI1 PHC1 HTT TBP | 4.96e-04 | 1207 | 25 | 14 | HP:0010993 |
| HumanPheno | Syringomyelia | 5.17e-04 | 33 | 25 | 3 | HP:0003396 | |
| HumanPheno | Frontal upsweep of hair | 5.17e-04 | 33 | 25 | 3 | HP:0002236 | |
| HumanPheno | Abnormal experience of reality | 5.48e-04 | 646 | 25 | 10 | HP:5200423 | |
| HumanPheno | Long thumb | 6.36e-04 | 8 | 25 | 2 | HP:0032524 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the hand | 6.60e-04 | 538 | 25 | 9 | HP:0005927 | |
| HumanPheno | Abnormal preputium morphology | 6.70e-04 | 36 | 25 | 3 | HP:0100587 | |
| HumanPheno | Nasolacrimal duct obstruction | 6.70e-04 | 36 | 25 | 3 | HP:0000579 | |
| HumanPheno | Regional abnormality of skin | 6.88e-04 | 541 | 25 | 9 | HP:0011356 | |
| HumanPheno | Atrial septal defect | 6.88e-04 | 541 | 25 | 9 | HP:0001631 | |
| HumanPheno | Abnormality of the atrial septum | 6.88e-04 | 541 | 25 | 9 | HP:0001630 | |
| HumanPheno | Supernumerary tooth | 6.99e-04 | 85 | 25 | 4 | HP:0011069 | |
| HumanPheno | Abnormal atrial septum morphology | 7.17e-04 | 544 | 25 | 9 | HP:0011994 | |
| HumanPheno | Brachydactyly (hand) | 7.21e-04 | 430 | 25 | 8 | HP:0100667 | |
| HumanPheno | Brachydactyly | 7.37e-04 | 670 | 25 | 10 | HP:0001156 | |
| HumanPheno | Short digit | 7.55e-04 | 672 | 25 | 10 | HP:0011927 | |
| HumanPheno | Thick eyebrow | 7.70e-04 | 154 | 25 | 5 | HP:0000574 | |
| HumanPheno | Clinodactyly of the 2nd finger | 8.15e-04 | 9 | 25 | 2 | HP:0040022 | |
| HumanPheno | Pilomatrixoma | 8.15e-04 | 9 | 25 | 2 | HP:0030434 | |
| HumanPheno | High, narrow palate | 8.17e-04 | 156 | 25 | 5 | HP:0002705 | |
| HumanPheno | Aplasia/hypoplasia of the extremities | ARID1B KMT2D BRD4 ATXN3 KCNN3 SIK3 RUNX2 CREBBP MED12 RAI1 HTT | 8.23e-04 | 813 | 25 | 11 | HP:0009815 |
| HumanPheno | Somatic sensory dysfunction | 8.28e-04 | 439 | 25 | 8 | HP:0003474 | |
| HumanPheno | Intestinal malrotation | 8.41e-04 | 157 | 25 | 5 | HP:0002566 | |
| HumanPheno | Abnormality of dental eruption | 8.54e-04 | 240 | 25 | 6 | HP:0006292 | |
| HumanPheno | Abnormality of the upper respiratory tract | ARID1B KMT2D FOXP2 POLG BRD4 ATXN3 RUNX2 CREBBP AR MED12 RAI1 HTT TBP | 8.64e-04 | 1111 | 25 | 13 | HP:0002087 |
| HumanPheno | Memory impairment | 8.66e-04 | 158 | 25 | 5 | HP:0002354 | |
| HumanPheno | Abnormally folded helix | 8.68e-04 | 90 | 25 | 4 | HP:0008544 | |
| MousePheno | abnormal craniofacial morphology | NCOA3 NCOR2 NCOA6 KMT2D FOXP2 ASCL1 GLG1 BRD4 MINK1 SIK3 RUNX2 MN1 CREBBP MED12 RAI1 PHC1 HTT THAP11 | 5.47e-08 | 1372 | 44 | 18 | MP:0000428 |
| MousePheno | craniofacial phenotype | NCOA3 NCOR2 NCOA6 KMT2D FOXP2 ASCL1 GLG1 BRD4 MINK1 SIK3 RUNX2 MN1 CREBBP MED12 RAI1 PHC1 HTT THAP11 | 5.47e-08 | 1372 | 44 | 18 | MP:0005382 |
| MousePheno | abnormal head morphology | NCOA3 NCOA6 KMT2D FOXP2 ASCL1 GLG1 BRD4 MINK1 RUNX2 MN1 CREBBP MED12 RAI1 PHC1 HTT | 8.19e-07 | 1120 | 44 | 15 | MP:0000432 |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | NCOA6 ATN1 FOXP2 GLG1 BRD4 ZFHX3 SIK3 RUNX2 NFAT5 MN1 CREBBP MEF2A RAI1 HTT TBP | 8.57e-07 | 1124 | 44 | 15 | MP:0011112 |
| MousePheno | neuronal intranuclear inclusions | 2.41e-06 | 9 | 44 | 3 | MP:0004191 | |
| MousePheno | abnormal fibrous joint morphology | 3.79e-06 | 135 | 44 | 6 | MP:0030878 | |
| MousePheno | abnormal axial skeleton morphology | NCOA3 KMT2D ATXN1 GLG1 POLG BRD4 MINK1 ZMYND8 SIK3 RUNX2 MN1 CREBBP RAI1 PHC1 HTT THAP11 | 4.39e-06 | 1458 | 44 | 16 | MP:0002114 |
| MousePheno | abnormal cranium morphology | NCOA3 KMT2D GLG1 BRD4 MINK1 SIK3 RUNX2 MN1 CREBBP RAI1 PHC1 HTT | 5.17e-06 | 813 | 44 | 12 | MP:0000438 |
| MousePheno | abnormal craniofacial bone morphology | NCOA3 KMT2D GLG1 BRD4 MINK1 SIK3 RUNX2 MN1 CREBBP RAI1 PHC1 HTT | 6.16e-06 | 827 | 44 | 12 | MP:0002116 |
| MousePheno | abnormal viscerocranium morphology | 1.18e-05 | 593 | 44 | 10 | MP:0005274 | |
| MousePheno | small nasal bone | 1.27e-05 | 46 | 44 | 4 | MP:0004470 | |
| MousePheno | large fontanelles | 1.58e-05 | 16 | 44 | 3 | MP:0030388 | |
| MousePheno | abnormal facial morphology | NCOA3 NCOA6 KMT2D ASCL1 GLG1 BRD4 MINK1 RUNX2 MN1 CREBBP RAI1 PHC1 | 1.63e-05 | 910 | 44 | 12 | MP:0003743 |
| MousePheno | abnormal jaw morphology | 3.27e-05 | 530 | 44 | 9 | MP:0000454 | |
| MousePheno | postnatal lethality, incomplete penetrance | 3.33e-05 | 669 | 44 | 10 | MP:0011086 | |
| MousePheno | abnormal fontanelle morphology | 4.93e-05 | 23 | 44 | 3 | MP:0000084 | |
| MousePheno | abnormal adiponectin level | 5.03e-05 | 65 | 44 | 4 | MP:0004891 | |
| MousePheno | lethality throughout fetal growth and development | 5.46e-05 | 435 | 44 | 8 | MP:0006208 | |
| MousePheno | abnormal cranial suture morphology | 5.66e-05 | 67 | 44 | 4 | MP:0002835 | |
| MousePheno | nasal bone hypoplasia | 5.79e-05 | 4 | 44 | 2 | MP:0000103 | |
| MousePheno | abnormal nasal bone morphology | 6.36e-05 | 69 | 44 | 4 | MP:0000102 | |
| MousePheno | abnormal craniofacial suture morphology | 6.73e-05 | 70 | 44 | 4 | MP:0030229 | |
| MousePheno | premature death | NCOA3 ATN1 FOXP2 ATXN1 POLG KCNN3 ZFHX3 RUNX2 CREBBP MEF2A AR HTT | 6.77e-05 | 1051 | 44 | 12 | MP:0002083 |
| MousePheno | abnormal appendicular skeleton morphology | NALF1 GLG1 BRD4 MINK1 MAMLD1 AAK1 SIK3 RUNX2 CREBBP RAI1 PHC1 | 7.64e-05 | 896 | 44 | 11 | MP:0009250 |
| MousePheno | increased grooming behavior | 8.37e-05 | 74 | 44 | 4 | MP:0001441 | |
| MousePheno | abnormal maxilla morphology | 8.50e-05 | 144 | 44 | 5 | MP:0000455 | |
| MousePheno | abnormal eating behavior | 9.02e-05 | 604 | 44 | 9 | MP:0001431 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | NCOR2 NCOA6 ARID1B FOXP2 ASCL1 RUNX2 MIDEAS NFAT5 MN1 CREBBP PHC1 HTT THAP11 | 9.53e-05 | 1269 | 44 | 13 | MP:0011111 |
| MousePheno | impaired coordination | 1.06e-04 | 478 | 44 | 8 | MP:0001405 | |
| MousePheno | increased adiponectin level | 1.11e-04 | 30 | 44 | 3 | MP:0004892 | |
| MousePheno | abnormal palatal shelf fusion at midline | 1.13e-04 | 80 | 44 | 4 | MP:0009887 | |
| MousePheno | abnormal vertebral column morphology | 1.30e-04 | 787 | 44 | 10 | MP:0004703 | |
| MousePheno | abnormal secondary palate morphology | 1.36e-04 | 159 | 44 | 5 | MP:0013550 | |
| MousePheno | perinatal lethality | NCOA6 ARID1B FOXP2 ASCL1 SIK3 RUNX2 NFAT5 MN1 CREBBP PHC1 HTT THAP11 | 1.36e-04 | 1130 | 44 | 12 | MP:0002081 |
| MousePheno | abnormal mouth morphology | 1.98e-04 | 670 | 44 | 9 | MP:0000452 | |
| MousePheno | short nasal bone | 2.10e-04 | 37 | 44 | 3 | MP:0004471 | |
| MousePheno | abnormal joint morphology | 2.18e-04 | 397 | 44 | 7 | MP:0002932 | |
| MousePheno | abnormal occipital bone morphology | 2.21e-04 | 95 | 44 | 4 | MP:0005269 | |
| MousePheno | decreased fat cell size | 2.39e-04 | 97 | 44 | 4 | MP:0009269 | |
| MousePheno | abnormal consumption behavior | 2.61e-04 | 695 | 44 | 9 | MP:0002069 | |
| MousePheno | abnormal vertebrae morphology | 2.63e-04 | 546 | 44 | 8 | MP:0000137 | |
| MousePheno | large anterior fontanelle | 2.68e-04 | 8 | 44 | 2 | MP:0000085 | |
| MousePheno | abnormal anterior fontanelle morphology | 2.68e-04 | 8 | 44 | 2 | MP:0030363 | |
| MousePheno | absent organized vascular network | 2.68e-04 | 8 | 44 | 2 | MP:0000263 | |
| MousePheno | short facial bone | 3.12e-04 | 104 | 44 | 4 | MP:0030384 | |
| MousePheno | limbs/digits/tail phenotype | NCOA6 NALF1 GLG1 BRD4 ZMYND8 MAMLD1 AAK1 SIK3 RUNX2 CREBBP RAI1 THAP11 | 3.71e-04 | 1258 | 44 | 12 | MP:0005371 |
| MousePheno | abnormal nose morphology | 4.03e-04 | 201 | 44 | 5 | MP:0002233 | |
| MousePheno | postnatal lethality | ATN1 FOXP2 GLG1 BRD4 ZFHX3 RUNX2 NFAT5 CREBBP MEF2A RAI1 TBP | 4.09e-04 | 1084 | 44 | 11 | MP:0002082 |
| MousePheno | abnormal postnatal growth | 4.12e-04 | 907 | 44 | 10 | MP:0001731 | |
| MousePheno | abnormal bile salt homeostasis | 4.28e-04 | 47 | 44 | 3 | MP:0005365 | |
| MousePheno | abnormal white adipose tissue morphology | 4.73e-04 | 321 | 44 | 6 | MP:0002970 | |
| MousePheno | abnormal palate morphology | 4.73e-04 | 321 | 44 | 6 | MP:0003755 | |
| MousePheno | abnormal energy homeostasis | 4.81e-04 | 322 | 44 | 6 | MP:0005448 | |
| MousePheno | abnormal gas homeostasis | 4.96e-04 | 600 | 44 | 8 | MP:0003948 | |
| MousePheno | limb grasping | 5.05e-04 | 325 | 44 | 6 | MP:0001513 | |
| MousePheno | abnormal thoracic cage morphology | 5.54e-04 | 463 | 44 | 7 | MP:0004624 | |
| MousePheno | abnormal palatal shelf morphology | 5.55e-04 | 121 | 44 | 4 | MP:0031460 | |
| MousePheno | abnormal secondary palate development | 6.09e-04 | 124 | 44 | 4 | MP:0009655 | |
| MousePheno | flattened snout | 6.26e-04 | 12 | 44 | 2 | MP:0000447 | |
| MousePheno | extramedullary hematopoiesis | 6.46e-04 | 126 | 44 | 4 | MP:0000240 | |
| MousePheno | cleft secondary palate | 6.66e-04 | 127 | 44 | 4 | MP:0009890 | |
| MousePheno | palatal shelves fail to meet at midline | 6.81e-04 | 55 | 44 | 3 | MP:0009888 | |
| MousePheno | abnormal heart ventricle morphology | 6.85e-04 | 793 | 44 | 9 | MP:0005294 | |
| MousePheno | abnormal palate development | 7.06e-04 | 129 | 44 | 4 | MP:0009653 | |
| MousePheno | decreased hormone level | 7.21e-04 | 635 | 44 | 8 | MP:0014455 | |
| MousePheno | short premaxilla | 7.39e-04 | 13 | 44 | 2 | MP:0000091 | |
| MousePheno | facial bone hypoplasia | 7.56e-04 | 57 | 44 | 3 | MP:0030386 | |
| MousePheno | abnormal adipose tissue morphology | NCOA3 NCOR2 NCOA6 KMT2D FOXP2 POLG ZMYND8 MAMLD1 SIK3 CREBBP AR RAI1 | 7.59e-04 | 1361 | 44 | 12 | MP:0000003 |
| MousePheno | increased hormone level | 7.67e-04 | 641 | 44 | 8 | MP:0014454 | |
| MousePheno | abnormal circulating leptin level | 8.35e-04 | 236 | 44 | 5 | MP:0005667 | |
| MousePheno | delayed cranial suture closure | 8.60e-04 | 14 | 44 | 2 | MP:0010743 | |
| MousePheno | adipose tissue phenotype | NCOA3 NCOR2 NCOA6 KMT2D FOXP2 POLG ZMYND8 MAMLD1 SIK3 CREBBP AR RAI1 | 8.76e-04 | 1383 | 44 | 12 | MP:0005375 |
| MousePheno | abnormal grooming behavior | 8.84e-04 | 137 | 44 | 4 | MP:0001440 | |
| MousePheno | abnormal white adipose tissue amount | 9.09e-04 | 138 | 44 | 4 | MP:0001781 | |
| MousePheno | thin ventricular wall | 9.09e-04 | 138 | 44 | 4 | MP:0000280 | |
| MousePheno | abnormal heart development | 1.02e-03 | 372 | 44 | 6 | MP:0000267 | |
| MousePheno | hypoactivity | 1.06e-03 | 1023 | 44 | 10 | MP:0031392 | |
| MousePheno | abnormal parietal bone morphology | 1.06e-03 | 64 | 44 | 3 | MP:0000109 | |
| MousePheno | abnormal tibia morphology | 1.07e-03 | 375 | 44 | 6 | MP:0000558 | |
| MousePheno | increased vertical activity | 1.08e-03 | 250 | 44 | 5 | MP:0002574 | |
| MousePheno | abnormal long bone morphology | 1.08e-03 | 676 | 44 | 8 | MP:0003723 | |
| MousePheno | small basisphenoid bone | 1.13e-03 | 16 | 44 | 2 | MP:0004462 | |
| MousePheno | abnormal hindlimb zeugopod morphology | 1.16e-03 | 381 | 44 | 6 | MP:0003857 | |
| MousePheno | decreased kidney weight | 1.16e-03 | 66 | 44 | 3 | MP:0003918 | |
| MousePheno | abnormal sternum morphology | 1.18e-03 | 255 | 44 | 5 | MP:0000157 | |
| MousePheno | abnormal myocardium compact layer morphology | 1.21e-03 | 67 | 44 | 3 | MP:0004056 | |
| MousePheno | abnormal hard palate morphology | 1.21e-03 | 67 | 44 | 3 | MP:0003756 | |
| MousePheno | abnormal learning/memory/conditioning | ARID1B KMT2D ATN1 FOXP2 ATXN1 TOX3 ATXN3 AAK1 CREBBP RAI1 HTT | 1.26e-03 | 1239 | 44 | 11 | MP:0002063 |
| MousePheno | abnormal cognition | ARID1B KMT2D ATN1 FOXP2 ATXN1 TOX3 ATXN3 AAK1 CREBBP RAI1 HTT | 1.32e-03 | 1246 | 44 | 11 | MP:0014114 |
| MousePheno | short stride length | 1.32e-03 | 69 | 44 | 3 | MP:0001407 | |
| MousePheno | lethality throughout fetal growth and development, complete penetrance | 1.35e-03 | 263 | 44 | 5 | MP:0011099 | |
| MousePheno | abnormal motor coordination/balance | 1.36e-03 | 873 | 44 | 9 | MP:0001516 | |
| MousePheno | abnormal bone marrow cell number | 1.37e-03 | 154 | 44 | 4 | MP:0000172 | |
| MousePheno | lowered ear position | 1.43e-03 | 18 | 44 | 2 | MP:0000024 | |
| MousePheno | postnatal growth retardation | 1.44e-03 | 881 | 44 | 9 | MP:0001732 | |
| MousePheno | abnormal neurocranium morphology | 1.50e-03 | 269 | 44 | 5 | MP:0000074 | |
| MousePheno | perinatal lethality, complete penetrance | 1.51e-03 | 712 | 44 | 8 | MP:0011089 | |
| MousePheno | abnormal hormone level | 1.52e-03 | 1073 | 44 | 10 | MP:0003953 | |
| MousePheno | decreased circulating hormone level | 1.53e-03 | 551 | 44 | 7 | MP:0014457 | |
| MousePheno | decreased susceptibility to diet-induced obesity | 1.57e-03 | 160 | 44 | 4 | MP:0005659 | |
| Domain | ARM-like | 8.21e-06 | 270 | 51 | 7 | IPR011989 | |
| Domain | Neuroggenic_mastermind-like_N | 2.19e-05 | 3 | 51 | 2 | IPR019082 | |
| Domain | MamL-1 | 2.19e-05 | 3 | 51 | 2 | PF09596 | |
| Domain | MamL-1 | 2.19e-05 | 3 | 51 | 2 | SM01275 | |
| Domain | Nuc_rcpt_coact | 1.09e-04 | 6 | 51 | 2 | IPR009110 | |
| Domain | Bromodomain | 1.51e-04 | 38 | 51 | 3 | PF00439 | |
| Domain | BROMODOMAIN_2 | 1.90e-04 | 41 | 51 | 3 | PS50014 | |
| Domain | BROMO | 2.04e-04 | 42 | 51 | 3 | SM00297 | |
| Domain | Bromodomain | 2.04e-04 | 42 | 51 | 3 | IPR001487 | |
| Domain | - | 2.04e-04 | 42 | 51 | 3 | 1.20.920.10 | |
| Domain | EPHD | 1.63e-03 | 22 | 51 | 2 | PS51805 | |
| Domain | Pentatricopeptide_repeat | 1.78e-03 | 23 | 51 | 2 | IPR002885 | |
| Domain | PHD | 1.85e-03 | 89 | 51 | 3 | SM00249 | |
| Domain | Znf_PHD | 1.97e-03 | 91 | 51 | 3 | IPR001965 | |
| Domain | ZF_PHD_2 | 2.22e-03 | 95 | 51 | 3 | PS50016 | |
| Domain | Bromodomain_CS | 2.28e-03 | 26 | 51 | 2 | IPR018359 | |
| Domain | SANT_dom | 2.28e-03 | 26 | 51 | 2 | IPR017884 | |
| Domain | ZF_PHD_1 | 2.29e-03 | 96 | 51 | 3 | PS01359 | |
| Domain | SANT | 2.64e-03 | 28 | 51 | 2 | PS51293 | |
| Domain | - | 3.14e-03 | 222 | 51 | 4 | 1.25.10.10 | |
| Domain | HLH | 3.46e-03 | 111 | 51 | 3 | PF00010 | |
| Domain | HLH | 3.91e-03 | 116 | 51 | 3 | SM00353 | |
| Domain | BHLH | 4.01e-03 | 117 | 51 | 3 | PS50888 | |
| Domain | bHLH_dom | 4.11e-03 | 118 | 51 | 3 | IPR011598 | |
| Domain | Myb_DNA-binding | 4.11e-03 | 35 | 51 | 2 | PF00249 | |
| Domain | BROMODOMAIN_1 | 4.58e-03 | 37 | 51 | 2 | PS00633 | |
| Domain | MYB_LIKE | 4.83e-03 | 38 | 51 | 2 | PS50090 | |
| Domain | PDZ | 6.73e-03 | 141 | 51 | 3 | PF00595 | |
| Domain | PDZ | 7.69e-03 | 148 | 51 | 3 | SM00228 | |
| Domain | - | 7.98e-03 | 150 | 51 | 3 | 2.30.42.10 | |
| Pathway | PID_HES_HEY_PATHWAY | 7.22e-09 | 48 | 44 | 6 | M288 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 2.18e-08 | 28 | 44 | 5 | M6177 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 8.08e-08 | 14 | 44 | 4 | M27808 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 1.46e-07 | 16 | 44 | 4 | M27121 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 2.20e-07 | 84 | 44 | 6 | M1008 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 3.26e-07 | 47 | 44 | 5 | M7946 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.63e-07 | 48 | 44 | 5 | M611 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.86e-07 | 20 | 44 | 4 | M27881 | |
| Pathway | BIOCARTA_RARRXR_PATHWAY | 5.64e-07 | 6 | 44 | 3 | MM1447 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 7.00e-07 | 23 | 44 | 4 | MM14954 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 9.50e-07 | 58 | 44 | 5 | M29616 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 9.95e-07 | 25 | 44 | 4 | M27880 | |
| Pathway | REACTOME_ADIPOGENESIS | 1.09e-06 | 110 | 44 | 6 | M48259 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 1.65e-06 | 118 | 44 | 6 | M27316 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | MED15 NCOR2 ARID1B KMT2D MAMLD1 ATXN3 ZFHX3 MAML2 RUNX2 CREBBP MAML3 AR MED12 PHC1 HTT TBP | 2.04e-06 | 1387 | 44 | 16 | M734 |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 3.22e-06 | 74 | 44 | 5 | M616 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 3.35e-06 | 10 | 44 | 3 | MM15535 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 5.35e-06 | 82 | 44 | 5 | MM15922 | |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 6.12e-06 | 12 | 44 | 3 | M27159 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 8.47e-06 | 42 | 44 | 4 | M17541 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 8.93e-06 | 91 | 44 | 5 | M39700 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 1.12e-05 | 45 | 44 | 4 | M39571 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 1.16e-05 | 96 | 44 | 5 | M27784 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 1.22e-05 | 46 | 44 | 4 | MM15971 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.58e-05 | 49 | 44 | 4 | M618 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | NCOR2 KMT2D MAMLD1 ATXN3 ZFHX3 MAML2 RUNX2 MAML3 AR PHC1 TBP | 1.71e-05 | 768 | 44 | 11 | MM14851 |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 2.24e-05 | 18 | 44 | 3 | MM14775 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 3.71e-05 | 122 | 44 | 5 | M29689 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 3.78e-05 | 61 | 44 | 4 | M39540 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | NCOR2 KMT2D MAMLD1 ATXN3 PAXIP1 ZFHX3 MAML2 RUNX2 MAML3 AR PHC1 TBP | 4.74e-05 | 1022 | 44 | 12 | MM15436 |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 4.87e-05 | 65 | 44 | 4 | M39682 | |
| Pathway | REACTOME_FORMATION_OF_PARAXIAL_MESODERM | 6.16e-05 | 69 | 44 | 4 | M46439 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 7.02e-05 | 26 | 44 | 3 | M2499 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | MED15 NCOA3 NCOR2 NCOA6 TSC22D1 ARID1B KMT2D MAMLD1 PAXIP1 MAML2 CREBBP MEF2A MAML3 MED12 | 7.15e-05 | 1432 | 44 | 14 | M509 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 8.99e-05 | 76 | 44 | 4 | MM15520 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 9.80e-05 | 29 | 44 | 3 | M48076 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 1.09e-04 | 30 | 44 | 3 | M207 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 1.21e-04 | 82 | 44 | 4 | M594 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 1.21e-04 | 82 | 44 | 4 | M2 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 1.45e-04 | 33 | 44 | 3 | M604 | |
| Pathway | REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_MYELOID_CELLS | 1.98e-04 | 7 | 44 | 2 | M27799 | |
| Pathway | REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT | 1.98e-04 | 7 | 44 | 2 | MM15533 | |
| Pathway | BIOCARTA_RARRXR_PATHWAY | 1.98e-04 | 7 | 44 | 2 | M6907 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 2.40e-04 | 39 | 44 | 3 | MM14604 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 2.99e-04 | 42 | 44 | 3 | M48018 | |
| Pathway | PID_HNF3A_PATHWAY | 3.44e-04 | 44 | 44 | 3 | M285 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 3.44e-04 | 44 | 44 | 3 | M27295 | |
| Pathway | REACTOME_HEME_SIGNALING | 4.73e-04 | 49 | 44 | 3 | M41832 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 5.05e-04 | 119 | 44 | 4 | M607 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 6.16e-04 | 12 | 44 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 6.16e-04 | 12 | 44 | 2 | M47533 | |
| Pathway | REACTOME_GASTRULATION | 6.84e-04 | 129 | 44 | 4 | M46433 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 7.27e-04 | 13 | 44 | 2 | M47534 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 8.19e-04 | 237 | 44 | 5 | M27786 | |
| Pathway | REACTOME_CYTOPROTECTION_BY_HMOX1 | 8.57e-04 | 60 | 44 | 3 | M41830 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 9.68e-04 | 246 | 44 | 5 | M10189 | |
| Pathway | WP_RUBINSTEINTAYBI_SYNDROME_1 | 9.74e-04 | 15 | 44 | 2 | M48323 | |
| Pathway | PID_RB_1PATHWAY | 1.08e-03 | 65 | 44 | 3 | M279 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 1.12e-03 | 254 | 44 | 5 | M27131 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 1.34e-03 | 70 | 44 | 3 | M938 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 1.41e-03 | 18 | 44 | 2 | M26942 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 2.11e-03 | 22 | 44 | 2 | MM1370 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 2.36e-03 | 301 | 44 | 5 | MM15983 | |
| Pathway | REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION | 2.52e-03 | 24 | 44 | 2 | M27803 | |
| Pathway | REACTOME_SUMOYLATION | 2.80e-03 | 189 | 44 | 4 | M27214 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 3.18e-03 | 27 | 44 | 2 | M39545 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 3.18e-03 | 27 | 44 | 2 | M26943 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 3.51e-03 | 98 | 44 | 3 | M48247 | |
| Pathway | REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT | 4.18e-03 | 31 | 44 | 2 | M27805 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 4.45e-03 | 32 | 44 | 2 | M27900 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 5.92e-03 | 37 | 44 | 2 | M27797 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 6.18e-03 | 120 | 44 | 3 | M48233 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 6.23e-03 | 38 | 44 | 2 | MM17073 | |
| Pubmed | MED15 MAGI1 NCOA3 NCOR2 KMT2D FOXP2 NUMBL CELF3 TOX3 PAXIP1 MAML3 MED12 | 7.02e-29 | 23 | 54 | 12 | 9225980 | |
| Pubmed | MED15 NCOA3 NCOA6 ARID1B KMT2D ATN1 ATXN1 BRD4 ZMYND8 PAXIP1 MIDEAS CREBBP MEF2A AR MED12 RAI1 | 1.60e-21 | 268 | 54 | 16 | 33640491 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | MED15 NCOA3 NCOR2 NCOA6 ARID1B KMT2D ATN1 FOXP2 ATXN1 PAXIP1 ZFHX3 MIDEAS CREBBP MED12 RAI1 | 5.16e-18 | 351 | 54 | 15 | 38297188 |
| Pubmed | 1.56e-13 | 7 | 54 | 5 | 11121205 | ||
| Pubmed | 1.04e-12 | 23 | 54 | 6 | 26002199 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | NCOA3 NCOR2 ARID1B KMT2D ZMYND8 IRF2BPL ZFHX3 MIDEAS AR MED12 | 1.57e-12 | 220 | 54 | 10 | 35785414 |
| Pubmed | MED15 NCOA3 NCOR2 NCOA6 ARID1B KMT2D ATN1 FOXP2 ATXN1 ZMYND8 PAXIP1 IRF2BPL ZFHX3 MIDEAS CREBBP MEF2A TBP THAP11 | 2.38e-12 | 1429 | 54 | 18 | 35140242 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAGI1 NCOR2 TSC22D1 USF3 NUMBL ATXN1 POLG MINK1 TOX3 AAK1 ZFHX3 NFAT5 CREBBP MEF2A MAML3 AR RAI1 HTT | 4.71e-12 | 1489 | 54 | 18 | 28611215 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | MED15 NCOA3 NCOR2 NCOA6 ARID1B KMT2D ATN1 MAMLD1 MIDEAS CREBBP MAML3 RAI1 | 4.78e-12 | 457 | 54 | 12 | 32344865 |
| Pubmed | MED15 NCOA3 NCOR2 NCOA6 ARID1B KMT2D BRD4 ZMYND8 PAXIP1 RUNX2 MIDEAS CREBBP MEF2A MED12 RAI1 THAP11 | 6.40e-12 | 1103 | 54 | 16 | 34189442 | |
| Pubmed | 3.52e-11 | 78 | 54 | 7 | 28611094 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | NCOA3 TSC22D1 KMT2D USF3 FOXP2 ASCL1 TOX3 ZFHX3 RUNX2 MIDEAS NFAT5 MEF2A AR THAP11 | 7.62e-11 | 908 | 54 | 14 | 19274049 |
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 28445460 | ||
| Pubmed | The ins and outs of a polyglutamine neurodegenerative disease: spinocerebellar ataxia type 1 (SCA1). | 1.81e-10 | 7 | 54 | 4 | 10860780 | |
| Pubmed | 1.81e-10 | 7 | 54 | 4 | 14756671 | ||
| Pubmed | Novel triplet repeat containing genes in human brain: cloning, expression, and length polymorphisms. | 1.81e-10 | 7 | 54 | 4 | 8325628 | |
| Pubmed | NCOA3 TSC22D1 FOXP2 ATXN1 BRD4 TOX3 ZMYND8 ZFHX3 RUNX2 NFAT5 MEF2A PHC1 TBP | 2.41e-10 | 808 | 54 | 13 | 20412781 | |
| Pubmed | 6.50e-10 | 9 | 54 | 4 | 9535906 | ||
| Pubmed | Screening for premutation in the FMR1 gene in male patients suspected of spinocerebellar ataxia. | 1.08e-09 | 10 | 54 | 4 | 19235102 | |
| Pubmed | MED15 NCOA3 NCOR2 NCOA6 ARID1B KMT2D PAXIP1 SIK3 CREBBP MAML3 RAI1 | 3.40e-09 | 638 | 54 | 11 | 31182584 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 15225551 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 16967484 | ||
| Pubmed | 3.62e-09 | 83 | 54 | 6 | 28794006 | ||
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 4.71e-09 | 40 | 54 | 5 | 34585037 | |
| Pubmed | 6.99e-09 | 15 | 54 | 4 | 9267036 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 7.60e-09 | 167 | 54 | 7 | 20362541 | |
| Pubmed | NCOR2 ARID1B ATN1 FOXP2 ATXN1 PHLDA1 BRD4 ZMYND8 ZFHX3 SIK3 CREBBP RAI1 TBP | 1.17e-08 | 1116 | 54 | 13 | 31753913 | |
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 11807410 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 18651325 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 17868456 | ||
| Pubmed | Expanded CAG Repeats in ATXN1, ATXN2, ATXN3, and HTT in the 1000 Genomes Project. | 1.41e-08 | 4 | 54 | 3 | 33159825 | |
| Pubmed | 2.47e-08 | 20 | 54 | 4 | 11877444 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA3 NCOR2 NCOA6 KMT2D ATN1 BRD4 MINK1 ZMYND8 AAK1 IRF2BPL MN1 | 2.48e-08 | 774 | 54 | 11 | 15302935 |
| Pubmed | 3.05e-08 | 21 | 54 | 4 | 19596656 | ||
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 18182848 | ||
| Pubmed | 5.74e-08 | 65 | 54 | 5 | 22496869 | ||
| Pubmed | 7.05e-08 | 6 | 54 | 3 | 23652004 | ||
| Pubmed | 7.05e-08 | 6 | 54 | 3 | 8896557 | ||
| Pubmed | 7.05e-08 | 6 | 54 | 3 | 16389595 | ||
| Pubmed | The candidate splicing factor Sfswap regulates growth and patterning of inner ear sensory organs. | 7.56e-08 | 26 | 54 | 4 | 24391519 | |
| Pubmed | 1.03e-07 | 28 | 54 | 4 | 24880616 | ||
| Pubmed | 1.23e-07 | 7 | 54 | 3 | 16858508 | ||
| Pubmed | 1.37e-07 | 152 | 54 | 6 | 38360978 | ||
| Pubmed | 1.61e-07 | 549 | 54 | 9 | 38280479 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.80e-07 | 398 | 54 | 8 | 35016035 | |
| Pubmed | 1.97e-07 | 8 | 54 | 3 | 17178841 | ||
| Pubmed | Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription. | 1.97e-07 | 8 | 54 | 3 | 30994454 | |
| Pubmed | 1.97e-07 | 8 | 54 | 3 | 17475621 | ||
| Pubmed | 2.61e-07 | 418 | 54 | 8 | 34709266 | ||
| Pubmed | 2.95e-07 | 9 | 54 | 3 | 19176441 | ||
| Pubmed | 3.31e-07 | 92 | 54 | 5 | 20301317 | ||
| Pubmed | The genetic aetiology of late-onset chronic progressive cerebellar ataxia. A population-based study. | 4.21e-07 | 10 | 54 | 3 | 19259763 | |
| Pubmed | Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. | 4.21e-07 | 10 | 54 | 3 | 16751102 | |
| Pubmed | 7.04e-07 | 107 | 54 | 5 | 11347906 | ||
| Pubmed | 7.71e-07 | 12 | 54 | 3 | 11158331 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 8.66e-07 | 877 | 54 | 10 | 20211142 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 9.77e-07 | 341 | 54 | 7 | 32971831 | |
| Pubmed | Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. | 1.00e-06 | 13 | 54 | 3 | 17761849 | |
| Pubmed | 1.00e-06 | 13 | 54 | 3 | 11266503 | ||
| Pubmed | 1.27e-06 | 14 | 54 | 3 | 12482968 | ||
| Pubmed | 1.36e-06 | 709 | 54 | 9 | 22988430 | ||
| Pubmed | 1.59e-06 | 15 | 54 | 3 | 10567404 | ||
| Pubmed | 1.59e-06 | 15 | 54 | 3 | 17925232 | ||
| Pubmed | Mastermind-like 1 (MamL1) and mastermind-like 3 (MamL3) are essential for Notch signaling in vivo. | 1.95e-06 | 16 | 54 | 3 | 22069191 | |
| Pubmed | 1.95e-06 | 16 | 54 | 3 | 24368734 | ||
| Pubmed | 2.01e-06 | 963 | 54 | 10 | 28671696 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 34953044 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 26253517 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 19223455 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 34077112 | ||
| Pubmed | Mutant huntingtin represses CBP, but not p300, by binding and protein degradation. | 2.37e-06 | 2 | 54 | 2 | 16456924 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 20140226 | ||
| Pubmed | MED12 and BRD4 cooperate to sustain cancer growth upon loss of mediator kinase. | 2.37e-06 | 2 | 54 | 2 | 34910943 | |
| Pubmed | A common motif targets huntingtin and the androgen receptor to the proteasome. | 2.37e-06 | 2 | 54 | 2 | 18586675 | |
| Pubmed | Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer. | 2.37e-06 | 2 | 54 | 2 | 24759320 | |
| Pubmed | Mutant huntingtin represses CBP, but not p300, by binding and protein degradation. | 2.37e-06 | 2 | 54 | 2 | 15994095 | |
| Pubmed | Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin. | 2.37e-06 | 2 | 54 | 2 | 16766198 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 20541699 | ||
| Pubmed | CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1. | 2.37e-06 | 2 | 54 | 2 | 9822653 | |
| Pubmed | Early alteration of epigenetic-related transcription in Huntington's disease mouse models. | 2.37e-06 | 2 | 54 | 2 | 29967375 | |
| Pubmed | A ketogenic diet rescues hippocampal memory defects in a mouse model of Kabuki syndrome. | 2.37e-06 | 2 | 54 | 2 | 27999180 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 16921507 | ||
| Pubmed | Regulation of androgen receptor activity by the nuclear receptor corepressor SMRT. | 2.37e-06 | 2 | 54 | 2 | 12441355 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 17627815 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 11927493 | ||
| Pubmed | Distinct behavioral and neuropathological abnormalities in transgenic mouse models of HD and DRPLA. | 2.37e-06 | 2 | 54 | 2 | 11442350 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 28675294 | ||
| Pubmed | Thyroid receptor activator molecule, TRAM-1, is an androgen receptor coactivator. | 2.37e-06 | 2 | 54 | 2 | 10965917 | |
| Pubmed | Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer. | 2.37e-06 | 2 | 54 | 2 | 11747336 | |
| Pubmed | Identification of SRC3/AIB1 as a preferred coactivator for hormone-activated androgen receptor. | 2.37e-06 | 2 | 54 | 2 | 20086010 | |
| Pubmed | The epigenetic reader Brd4 is required for osteoblast differentiation. | 2.37e-06 | 2 | 54 | 2 | 31868237 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 36898841 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 10410676 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 19492089 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 11264541 | ||
| Pubmed | Methylation specifies distinct estrogen-induced binding site repertoires of CBP to chromatin. | 2.37e-06 | 2 | 54 | 2 | 21632823 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 36029989 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 8662987 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 22116937 | ||
| Pubmed | The amino terminus of the human AR is target for corepressor action and antihormone agonism. | 2.37e-06 | 2 | 54 | 2 | 11923464 | |
| Interaction | GSC interactions | NCOA3 NCOR2 ARID1B KMT2D ATN1 FOXP2 ATXN1 PAXIP1 ZFHX3 MIDEAS CREBBP | 2.64e-16 | 87 | 52 | 11 | int:GSC |
| Interaction | CRX interactions | MED15 NCOA3 NCOR2 ARID1B KMT2D ATN1 FOXP2 ATXN1 PAXIP1 ZFHX3 MIDEAS CREBBP MED12 RAI1 | 2.06e-15 | 254 | 52 | 14 | int:CRX |
| Interaction | AR interactions | MED15 NCOA3 NCOR2 NCOA6 ARID1B KMT2D ATN1 ATXN1 BRD4 ZMYND8 PAXIP1 IRF2BPL ZFHX3 RUNX2 MIDEAS CREBBP MEF2A AR MED12 RAI1 TBP | 1.25e-14 | 992 | 52 | 21 | int:AR |
| Interaction | EGR2 interactions | NCOA3 NCOR2 NCOA6 ARID1B KMT2D ATN1 FOXP2 ATXN1 PAXIP1 ZFHX3 MIDEAS CREBBP | 1.45e-14 | 171 | 52 | 12 | int:EGR2 |
| Interaction | SOX9 interactions | NCOA3 NCOA6 ARID1B KMT2D BRD4 PAXIP1 RUNX2 MIDEAS CREBBP MED12 | 5.55e-14 | 97 | 52 | 10 | int:SOX9 |
| Interaction | TBR1 interactions | NCOA3 NCOR2 ARID1B KMT2D FOXP2 ATXN1 BRD4 PAXIP1 ZFHX3 MIDEAS | 2.66e-13 | 113 | 52 | 10 | int:TBR1 |
| Interaction | TBXT interactions | NCOA3 NCOR2 NCOA6 ARID1B KMT2D ATN1 ATXN1 PAXIP1 MIDEAS CREBBP | 3.47e-13 | 116 | 52 | 10 | int:TBXT |
| Interaction | PAX9 interactions | NCOA3 NCOR2 NCOA6 ARID1B KMT2D ATN1 ATXN1 PAXIP1 ZFHX3 MIDEAS | 1.10e-12 | 130 | 52 | 10 | int:PAX9 |
| Interaction | KLF5 interactions | NCOA3 NCOR2 NCOA6 ARID1B KMT2D ATXN1 BRD4 PAXIP1 CREBBP AR TBP | 2.24e-12 | 195 | 52 | 11 | int:KLF5 |
| Interaction | NFIB interactions | 2.69e-12 | 142 | 52 | 10 | int:NFIB | |
| Interaction | FEV interactions | NCOA3 NCOR2 NCOA6 ARID1B KMT2D FOXP2 ATXN1 PAXIP1 ZFHX3 MIDEAS CREBBP | 3.48e-12 | 203 | 52 | 11 | int:FEV |
| Interaction | ETV4 interactions | 8.29e-12 | 69 | 52 | 8 | int:ETV4 | |
| Interaction | ERG interactions | NCOA3 NCOR2 NCOA6 ARID1B KMT2D ATXN1 BRD4 PAXIP1 MIDEAS CREBBP AR | 9.65e-12 | 223 | 52 | 11 | int:ERG |
| Interaction | CREBBP interactions | NCOA3 NCOR2 NCOA6 ARID1B KMT2D ATXN1 PHLDA1 BRD4 ATXN3 MAML2 RUNX2 CREBBP AR HTT TBP | 1.70e-11 | 599 | 52 | 15 | int:CREBBP |
| Interaction | TEAD1 interactions | NCOR2 ARID1B KMT2D ATXN1 PAXIP1 ZFHX3 MIDEAS CREBBP MEF2A TBP | 2.30e-11 | 176 | 52 | 10 | int:TEAD1 |
| Interaction | PAX7 interactions | 2.77e-11 | 124 | 52 | 9 | int:PAX7 | |
| Interaction | NFIA interactions | MED15 NCOA3 NCOR2 ARID1B KMT2D ATXN1 PAXIP1 MIDEAS CREBBP AR | 4.42e-11 | 188 | 52 | 10 | int:NFIA |
| Interaction | GATA2 interactions | NCOA3 NCOR2 NCOA6 ARID1B KMT2D ATXN1 PAXIP1 ZFHX3 MIDEAS CREBBP | 7.75e-11 | 199 | 52 | 10 | int:GATA2 |
| Interaction | HNF4A interactions | NCOA3 NCOR2 NCOA6 ARID1B KMT2D ATXN1 PAXIP1 MIDEAS CREBBP AR TBP | 9.21e-11 | 275 | 52 | 11 | int:HNF4A |
| Interaction | NCOA6 interactions | 1.14e-10 | 145 | 52 | 9 | int:NCOA6 | |
| Interaction | PAX6 interactions | NCOA3 NCOR2 NCOA6 ARID1B KMT2D ATXN1 PAXIP1 ZFHX3 MIDEAS CREBBP AR TBP | 1.16e-10 | 366 | 52 | 12 | int:PAX6 |
| Interaction | NFIC interactions | 1.32e-10 | 210 | 52 | 10 | int:NFIC | |
| Interaction | TLE3 interactions | MED15 NCOA3 NCOR2 ARID1B KMT2D ATN1 ATXN1 BRD4 ZFHX3 MIDEAS CREBBP AR | 1.58e-10 | 376 | 52 | 12 | int:TLE3 |
| Interaction | SP7 interactions | NCOA3 NCOR2 NCOA6 ARID1B KMT2D ATN1 ATXN1 PAXIP1 MIDEAS CREBBP MEF2A | 2.68e-10 | 304 | 52 | 11 | int:SP7 |
| Interaction | PAX8 interactions | 4.04e-10 | 111 | 52 | 8 | int:PAX8 | |
| Interaction | GCM1 interactions | 4.30e-10 | 68 | 52 | 7 | int:GCM1 | |
| Interaction | TLX1 interactions | 6.10e-10 | 175 | 52 | 9 | int:TLX1 | |
| Interaction | NUP35 interactions | MED15 NCOA3 NCOR2 NCOA6 ARID1B KMT2D ATN1 MAMLD1 MIDEAS CREBBP MAML3 RAI1 | 6.22e-10 | 424 | 52 | 12 | int:NUP35 |
| Interaction | ETS1 interactions | 8.06e-10 | 121 | 52 | 8 | int:ETS1 | |
| Interaction | HNF1B interactions | 1.26e-09 | 190 | 52 | 9 | int:HNF1B | |
| Interaction | PAX2 interactions | 2.12e-09 | 85 | 52 | 7 | int:PAX2 | |
| Interaction | SUMO1 interactions | 2.74e-09 | 287 | 52 | 10 | int:SUMO1 | |
| Interaction | RELA interactions | MED15 NCOA3 NCOR2 NCOA6 KMT2D ATXN1 GLG1 ATXN3 ZFHX3 CREBBP AR TBP | 2.84e-09 | 485 | 52 | 12 | int:RELA |
| Interaction | SOX17 interactions | 4.65e-09 | 95 | 52 | 7 | int:SOX17 | |
| Interaction | CTBP1 interactions | 5.58e-09 | 406 | 52 | 11 | int:CTBP1 | |
| Interaction | FOS interactions | NCOA3 NCOR2 NCOA6 ARID1B KMT2D PAXIP1 RUNX2 NFAT5 CREBBP TBP | 6.10e-09 | 312 | 52 | 10 | int:FOS |
| Interaction | CEBPA interactions | MED15 NCOA3 NCOR2 NCOA6 ARID1B KMT2D BRD4 ZMYND8 PAXIP1 RUNX2 MIDEAS CREBBP MEF2A AR MED12 RAI1 THAP11 | 6.94e-09 | 1245 | 52 | 17 | int:CEBPA |
| Interaction | LHX3 interactions | 2.31e-08 | 185 | 52 | 8 | int:LHX3 | |
| Interaction | MYOD1 interactions | 3.34e-08 | 194 | 52 | 8 | int:MYOD1 | |
| Interaction | E2F1 interactions | 4.23e-08 | 200 | 52 | 8 | int:E2F1 | |
| Interaction | MED15 interactions | 4.38e-08 | 131 | 52 | 7 | int:MED15 | |
| Interaction | TLX3 interactions | 5.15e-08 | 291 | 52 | 9 | int:TLX3 | |
| Interaction | HCFC1 interactions | 5.46e-08 | 293 | 52 | 9 | int:HCFC1 | |
| Interaction | SOX7 interactions | 6.61e-08 | 82 | 52 | 6 | int:SOX7 | |
| Interaction | HDAC1 interactions | NCOR2 KMT2D ATXN1 BRD4 ZMYND8 ZFHX3 RUNX2 MIDEAS CREBBP MEF2A AR MED12 RAI1 TBP THAP11 | 7.57e-08 | 1108 | 52 | 15 | int:HDAC1 |
| Interaction | IRF4 interactions | 8.20e-08 | 85 | 52 | 6 | int:IRF4 | |
| Interaction | HDAC3 interactions | 9.60e-08 | 313 | 52 | 9 | int:HDAC3 | |
| Interaction | KMT2A interactions | 9.86e-08 | 314 | 52 | 9 | int:KMT2A | |
| Interaction | NCOA3 interactions | 1.02e-07 | 224 | 52 | 8 | int:NCOA3 | |
| Interaction | NFIX interactions | 1.13e-07 | 227 | 52 | 8 | int:NFIX | |
| Interaction | FOXI1 interactions | 1.32e-07 | 92 | 52 | 6 | int:FOXI1 | |
| Interaction | KLF4 interactions | 1.73e-07 | 160 | 52 | 7 | int:KLF4 | |
| Interaction | KDM6A interactions | 1.88e-07 | 162 | 52 | 7 | int:KDM6A | |
| Interaction | GATA1 interactions | 2.72e-07 | 171 | 52 | 7 | int:GATA1 | |
| Interaction | JUN interactions | 2.85e-07 | 470 | 52 | 10 | int:JUN | |
| Interaction | TPRX2 interactions | 3.25e-07 | 56 | 52 | 5 | int:TPRX2 | |
| Interaction | MED23 interactions | 3.78e-07 | 266 | 52 | 8 | int:MED23 | |
| Interaction | THRA interactions | 4.04e-07 | 111 | 52 | 6 | int:THRA | |
| Interaction | BAG2 interactions | NCOA6 ATXN1 POLG BRD4 ATXN3 AAK1 IRF2BPL CREBBP MED12 PHC1 HTT | 4.24e-07 | 622 | 52 | 11 | int:BAG2 |
| Interaction | GATA3 interactions | 4.98e-07 | 187 | 52 | 7 | int:GATA3 | |
| Interaction | PIN1 interactions | 5.26e-07 | 383 | 52 | 9 | int:PIN1 | |
| Interaction | SMAD2 interactions | 5.50e-07 | 385 | 52 | 9 | int:SMAD2 | |
| Interaction | NR3C1 interactions | MED15 NCOA3 NCOR2 NCOA6 ARID1B KMT2D PAXIP1 SIK3 CREBBP MAML3 AR RAI1 TBP | 7.94e-07 | 974 | 52 | 13 | int:NR3C1 |
| Interaction | DPY30 interactions | 8.94e-07 | 204 | 52 | 7 | int:DPY30 | |
| Interaction | MDC1 interactions | 1.01e-06 | 414 | 52 | 9 | int:MDC1 | |
| Interaction | KMT2B interactions | 1.02e-06 | 130 | 52 | 6 | int:KMT2B | |
| Interaction | KMT2C interactions | 1.22e-06 | 134 | 52 | 6 | int:KMT2C | |
| Interaction | EP300 interactions | NCOA3 NCOR2 NCOA6 KMT2D ASCL1 BRD4 ATXN3 PAXIP1 MAML2 RUNX2 MN1 CREBBP MEF2A AR TBP | 1.53e-06 | 1401 | 52 | 15 | int:EP300 |
| Interaction | TLX2 interactions | 1.72e-06 | 142 | 52 | 6 | int:TLX2 | |
| Interaction | SMAD3 interactions | 1.89e-06 | 447 | 52 | 9 | int:SMAD3 | |
| Interaction | NCOA1 interactions | 2.02e-06 | 146 | 52 | 6 | int:NCOA1 | |
| Interaction | CASP1 interactions | 2.79e-06 | 86 | 52 | 5 | int:CASP1 | |
| Interaction | EYA4 interactions | 2.86e-06 | 243 | 52 | 7 | int:EYA4 | |
| Interaction | YAP1 interactions | MED15 NCOA6 ARID1B KMT2D ATN1 BRD4 ATXN3 RUNX2 MIDEAS NFAT5 CREBBP AR MED12 | 2.93e-06 | 1095 | 52 | 13 | int:YAP1 |
| Interaction | MEF2D interactions | 2.96e-06 | 87 | 52 | 5 | int:MEF2D | |
| Interaction | PIAS1 interactions | 3.15e-06 | 353 | 52 | 8 | int:PIAS1 | |
| Interaction | MED21 interactions | 3.31e-06 | 159 | 52 | 6 | int:MED21 | |
| Interaction | PML interactions | MED15 NCOR2 NUMBL ATXN1 BRD4 MAMLD1 ATXN3 AAK1 PAXIP1 RUNX2 CREBBP HTT | 3.36e-06 | 933 | 52 | 12 | int:PML |
| Interaction | TBP interactions | 3.74e-06 | 253 | 52 | 7 | int:TBP | |
| Interaction | NUP43 interactions | NCOR2 NCOA6 ARID1B KMT2D ATN1 TOX3 ZMYND8 ZFHX3 MIDEAS MED12 | 3.74e-06 | 625 | 52 | 10 | int:NUP43 |
| Interaction | NCOR1 interactions | 3.87e-06 | 363 | 52 | 8 | int:NCOR1 | |
| Interaction | SOX10 interactions | 3.90e-06 | 92 | 52 | 5 | int:SOX10 | |
| Interaction | PIAS3 interactions | 4.57e-06 | 95 | 52 | 5 | int:PIAS3 | |
| Interaction | RXRA interactions | 4.71e-06 | 169 | 52 | 6 | int:RXRA | |
| Interaction | NCOR2 interactions | 4.95e-06 | 264 | 52 | 7 | int:NCOR2 | |
| Interaction | CASP7 interactions | 5.06e-06 | 97 | 52 | 5 | int:CASP7 | |
| Interaction | MED27 interactions | 6.47e-06 | 102 | 52 | 5 | int:MED27 | |
| Interaction | NR1I3 interactions | 7.05e-06 | 48 | 52 | 4 | int:NR1I3 | |
| Interaction | FHL2 interactions | 7.32e-06 | 396 | 52 | 8 | int:FHL2 | |
| Interaction | LHX2 interactions | 7.43e-06 | 183 | 52 | 6 | int:LHX2 | |
| Interaction | PSME3 interactions | 7.59e-06 | 398 | 52 | 8 | int:PSME3 | |
| Interaction | TP53BP1 interactions | 7.91e-06 | 533 | 52 | 9 | int:TP53BP1 | |
| Interaction | RBBP5 interactions | 8.54e-06 | 287 | 52 | 7 | int:RBBP5 | |
| Interaction | PAGR1 interactions | 9.00e-06 | 51 | 52 | 4 | int:PAGR1 | |
| Interaction | EN1 interactions | 9.37e-06 | 110 | 52 | 5 | int:EN1 | |
| Interaction | IRF2BP2 interactions | 9.37e-06 | 110 | 52 | 5 | int:IRF2BP2 | |
| Interaction | IRF2BPL interactions | 1.05e-05 | 53 | 52 | 4 | int:IRF2BPL | |
| Interaction | FOXL1 interactions | 1.10e-05 | 196 | 52 | 6 | int:FOXL1 | |
| Interaction | PPARG interactions | 1.32e-05 | 307 | 52 | 7 | int:PPARG | |
| Interaction | MLKL interactions | 1.41e-05 | 57 | 52 | 4 | int:MLKL | |
| Cytoband | 16q22.3 | 6.07e-05 | 10 | 54 | 2 | 16q22.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q22 | 1.33e-03 | 183 | 54 | 3 | chr16q22 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | MED15 MAGI1 NCOA3 NCOR2 KMT2D FOXP2 NUMBL CELF3 TOX3 PAXIP1 MAML3 MED12 | 1.11e-27 | 25 | 34 | 12 | 775 |
| GeneFamily | Ataxins|MJD deubiquinating enzymes | 5.12e-05 | 6 | 34 | 2 | 411 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 4.59e-04 | 17 | 34 | 2 | 486 | |
| GeneFamily | Cyclins|Mediator complex | 1.75e-03 | 33 | 34 | 2 | 1061 | |
| GeneFamily | PDZ domain containing | 2.88e-03 | 152 | 34 | 3 | 1220 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 4.45e-03 | 53 | 34 | 2 | 532 | |
| GeneFamily | PHD finger proteins | 1.24e-02 | 90 | 34 | 2 | 88 | |
| GeneFamily | Basic helix-loop-helix proteins | 1.81e-02 | 110 | 34 | 2 | 420 | |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 6.08e-08 | 171 | 54 | 7 | M39234 | |
| Coexpression | LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX | 4.55e-07 | 141 | 54 | 6 | M39235 | |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 6.07e-07 | 240 | 54 | 7 | M39236 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA3 NCOR2 NALF1 ATXN1 ZMYND8 MAMLD1 ZFHX3 SIK3 MN1 CREBBP MEF2A | 1.12e-06 | 856 | 54 | 11 | M4500 |
| Coexpression | GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_DN | 3.29e-06 | 198 | 54 | 6 | M7480 | |
| Coexpression | GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP | 3.49e-06 | 200 | 54 | 6 | M9449 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP | 3.68e-06 | 778 | 54 | 10 | M17915 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | NALF1 CELF3 TOX3 ZMYND8 KCNN3 IRF2BPL ZFHX3 FRMPD3 SIK3 FAM171B RAI1 | 1.30e-05 | 1106 | 54 | 11 | M39071 |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP | 1.95e-05 | 942 | 54 | 10 | M8144 | |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 2.57e-05 | 169 | 54 | 5 | M39230 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_LN_TREG_UP | 3.12e-05 | 176 | 54 | 5 | M8952 | |
| Coexpression | GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP | 3.57e-05 | 181 | 54 | 5 | M6849 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | 4.21e-05 | 822 | 54 | 9 | M6782 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | 4.37e-05 | 634 | 54 | 8 | M40866 | |
| Coexpression | GSE19512_NAUTRAL_VS_INDUCED_TREG_UP | 5.35e-05 | 197 | 54 | 5 | M8361 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML1 | 5.71e-05 | 328 | 54 | 6 | M39064 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN | 5.74e-05 | 200 | 54 | 5 | M9472 | |
| Coexpression | GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP | 5.74e-05 | 200 | 54 | 5 | M9458 | |
| Coexpression | GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_UP | 5.74e-05 | 200 | 54 | 5 | M9391 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 6.91e-05 | 208 | 54 | 5 | M39233 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | 7.52e-05 | 685 | 54 | 8 | MM3782 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_AIRWAY_PROGENITOR_CELL | 7.74e-05 | 40 | 54 | 3 | M45691 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 1.34e-04 | 126 | 54 | 4 | M39132 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING | 1.56e-04 | 394 | 54 | 6 | MM3724 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | 1.69e-04 | 574 | 54 | 7 | M8215 | |
| Coexpression | SCHEIDEREIT_IKK_INTERACTING_PROTEINS | 1.80e-04 | 53 | 54 | 3 | M6303 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | NCOA3 KMT2D ATXN1 PHLDA1 GLG1 DENND4B AAK1 SIK3 RUNX2 NFAT5 CREBBP | 1.94e-04 | 1492 | 54 | 11 | M40023 |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | 2.22e-04 | 600 | 54 | 7 | MM1025 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP | 2.26e-04 | 11 | 54 | 2 | M1358 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP | 2.26e-04 | 11 | 54 | 2 | MM569 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | 2.32e-04 | 807 | 54 | 8 | M16651 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | 2.42e-04 | 272 | 54 | 5 | MM3825 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL | 2.47e-04 | 429 | 54 | 6 | M45694 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 2.96e-04 | 155 | 54 | 4 | M39246 | |
| Coexpression | ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP | 3.26e-04 | 452 | 54 | 6 | M18685 | |
| Coexpression | RODRIGUES_NTN1_TARGETS_DN | 3.41e-04 | 161 | 54 | 4 | M11857 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBM | 3.52e-04 | 295 | 54 | 5 | M39063 | |
| Coexpression | KIM_WT1_TARGETS_12HR_UP | 3.83e-04 | 166 | 54 | 4 | M15535 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_DN | 4.46e-04 | 72 | 54 | 3 | M40882 | |
| Coexpression | GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_UP | 4.99e-04 | 178 | 54 | 4 | M6326 | |
| Coexpression | OKUMURA_INFLAMMATORY_RESPONSE_LPS | 5.42e-04 | 182 | 54 | 4 | M1911 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | 5.92e-04 | 506 | 54 | 6 | M39067 | |
| Coexpression | HAHTOLA_MYCOSIS_FUNGOIDES_UP | 6.24e-04 | 18 | 54 | 2 | M6714 | |
| Coexpression | SCHEIDEREIT_IKK_TARGETS | 6.24e-04 | 18 | 54 | 2 | M17115 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN | 6.25e-04 | 189 | 54 | 4 | M8275 | |
| Coexpression | GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_BCELL_UP | 6.37e-04 | 190 | 54 | 4 | M9871 | |
| Coexpression | GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_UP | 6.76e-04 | 193 | 54 | 4 | M9056 | |
| Coexpression | GSE6259_BCELL_VS_CD8_TCELL_UP | 6.76e-04 | 193 | 54 | 4 | M6735 | |
| Coexpression | KANG_DOXORUBICIN_RESISTANCE_DN | 6.97e-04 | 19 | 54 | 2 | M3323 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN | 7.00e-04 | 84 | 54 | 3 | M13008 | |
| Coexpression | VEGF_A_UP.V1_UP | 7.02e-04 | 195 | 54 | 4 | M2676 | |
| Coexpression | GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_UP | 7.16e-04 | 196 | 54 | 4 | M4530 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP | 7.16e-04 | 196 | 54 | 4 | M5381 | |
| Coexpression | GSE20727_CTRL_VS_H2O2_TREATED_DC_DN | 7.16e-04 | 196 | 54 | 4 | M9243 | |
| Coexpression | ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN | 7.24e-04 | 85 | 54 | 3 | M41085 | |
| Coexpression | GSE8515_CTRL_VS_IL1_4H_STIM_MAC_DN | 7.30e-04 | 197 | 54 | 4 | M5760 | |
| Coexpression | GSE16266_CTRL_VS_LPS_STIM_MEF_UP | 7.44e-04 | 198 | 54 | 4 | M7219 | |
| Coexpression | GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 7.44e-04 | 198 | 54 | 4 | M8624 | |
| Coexpression | GSE20727_CTRL_VS_H2O2_TREATED_DC_UP | 7.44e-04 | 198 | 54 | 4 | M9245 | |
| Coexpression | GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP | 7.44e-04 | 198 | 54 | 4 | M6123 | |
| Coexpression | GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP | 7.58e-04 | 199 | 54 | 4 | M7596 | |
| Coexpression | GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN | 7.58e-04 | 199 | 54 | 4 | M7607 | |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 7.58e-04 | 199 | 54 | 4 | M7254 | |
| Coexpression | GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 7.58e-04 | 199 | 54 | 4 | M8606 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP | 7.58e-04 | 199 | 54 | 4 | M9964 | |
| Coexpression | GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_UP | 7.58e-04 | 199 | 54 | 4 | M3182 | |
| Coexpression | GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN | 7.72e-04 | 200 | 54 | 4 | M5063 | |
| Coexpression | GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN | 7.72e-04 | 200 | 54 | 4 | M5059 | |
| Coexpression | GSE40655_FOXO1_KO_VS_WT_NTREG_UP | 7.72e-04 | 200 | 54 | 4 | M9439 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN | 7.72e-04 | 200 | 54 | 4 | M9463 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP | 7.72e-04 | 200 | 54 | 4 | M8050 | |
| Coexpression | GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_DN | 7.72e-04 | 200 | 54 | 4 | M7653 | |
| Coexpression | GSE27786_CD4_VS_CD8_TCELL_UP | 7.72e-04 | 200 | 54 | 4 | M4819 | |
| Coexpression | GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_DN | 7.72e-04 | 200 | 54 | 4 | M4876 | |
| Coexpression | GSE23925_DARK_ZONE_VS_NAIVE_BCELL_DN | 7.72e-04 | 200 | 54 | 4 | M7881 | |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_UP | 7.72e-04 | 200 | 54 | 4 | M7294 | |
| Coexpression | GSE19198_CTRL_VS_IL21_TREATED_TCELL_24H_DN | 7.72e-04 | 200 | 54 | 4 | M7231 | |
| Coexpression | GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_DN | 7.72e-04 | 200 | 54 | 4 | M9763 | |
| Coexpression | GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP | 7.72e-04 | 200 | 54 | 4 | M9843 | |
| Coexpression | GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_2H_UP | 7.72e-04 | 200 | 54 | 4 | M8733 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | 7.76e-04 | 1215 | 54 | 9 | M41122 | |
| Coexpression | SHEPARD_BMYB_MORPHOLINO_DN | 8.01e-04 | 202 | 54 | 4 | M11840 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 8.62e-04 | 206 | 54 | 4 | M2817 | |
| Coexpression | BENPORATH_NANOG_TARGETS | 8.85e-04 | 988 | 54 | 8 | M6616 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 8.93e-04 | 208 | 54 | 4 | MM581 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_VS_70PLS_0DY_UP | 9.37e-04 | 22 | 54 | 2 | M40867 | |
| Coexpression | HOEBEKE_LYMPHOID_STEM_CELL_UP | 1.06e-03 | 97 | 54 | 3 | M14698 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING | 1.08e-03 | 568 | 54 | 6 | MM3824 | |
| Coexpression | SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP | 1.13e-03 | 99 | 54 | 3 | M3238 | |
| Coexpression | BROWNE_HCMV_INFECTION_12HR_DN | 1.16e-03 | 100 | 54 | 3 | M5775 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#4 | NUMBL ATXN1 ASCL1 DENND4B TOX3 MAMLD1 AAK1 KCNN3 IRF2BPL FAM171B | 7.39e-06 | 683 | 54 | 10 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#2 | 3.86e-05 | 659 | 54 | 9 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | MAGI1 NUMBL ATXN1 ASCL1 CELF3 DENND4B MAMLD1 KCNN3 FAM171B TBP | 7.32e-05 | 893 | 54 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_200 | 8.19e-05 | 175 | 54 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | 8.67e-05 | 732 | 54 | 9 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_100 | 1.22e-04 | 100 | 54 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_100 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 1.54e-04 | 790 | 54 | 9 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | MAGI1 ATXN1 ASCL1 CELF3 DENND4B TOX3 MAMLD1 IRF2BPL FAM171B LIN7A | 1.61e-04 | 983 | 54 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.92e-04 | 210 | 54 | 5 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 2.40e-04 | 493 | 54 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.41e-04 | 658 | 54 | 8 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#5_top-relative-expression-ranked_500 | 2.80e-04 | 50 | 54 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500_k5 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-09 | 189 | 54 | 7 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 3.98e-09 | 196 | 54 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 4.27e-09 | 198 | 54 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 4.42e-09 | 199 | 54 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.25e-07 | 193 | 54 | 6 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-IPC_like|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.30e-06 | 156 | 54 | 5 | 7e6805ebc7bc2f9c5965321d16922c155719970f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-IPC_like-IPs_and_early_cortical_neurons|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.30e-06 | 156 | 54 | 5 | 741de05295b2d012ac8576378f37709a97c8fb50 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 2.41e-06 | 177 | 54 | 5 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.48e-06 | 178 | 54 | 5 | e86ed30652c2de70f16430f04b78789b87df4af2 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.07e-06 | 186 | 54 | 5 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.07e-06 | 186 | 54 | 5 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.15e-06 | 187 | 54 | 5 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.24e-06 | 188 | 54 | 5 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.24e-06 | 188 | 54 | 5 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.24e-06 | 188 | 54 | 5 | ee572246e0c2f41bdbc29a03edc67b831af95c09 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.59e-06 | 192 | 54 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 3.68e-06 | 193 | 54 | 5 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.96e-06 | 196 | 54 | 5 | fe2dd3a93fe22da93e24a400e154a68757985fc8 | |
| ToppCell | IPF-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 3.96e-06 | 196 | 54 | 5 | 6e70c48a63d9673eb16b0847c1bd88eecc2f7a3c | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.27e-06 | 199 | 54 | 5 | 94baf00dad27964392c3fc34970a4e79d576d0d3 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.37e-06 | 200 | 54 | 5 | c74bc12e13d002dedaaf75a2244ec111e47524e1 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.37e-06 | 200 | 54 | 5 | ead9eb579bb25fde05fc15602e3d05ab6617f7ac | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.37e-06 | 200 | 54 | 5 | d0167f96314be78b6d867bbcc6e4396071d931b8 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-GMP|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.89e-05 | 166 | 54 | 4 | d96e88e73a40205f32cebd7e54ca1ff09ee1e7e8 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue | 5.01e-05 | 167 | 54 | 4 | cb396f3edb9e8fdc316091e8e193dbba50e0be0c | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.49e-05 | 171 | 54 | 4 | 4e856441063e9825b6f87a1d3dd19c77dae4662c | |
| ToppCell | nucseq-Epithelial-Epithelial_Neuro-Secretory-PNEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.49e-05 | 171 | 54 | 4 | f4321133190a3df9d31f5d4021a464d3840145f1 | |
| ToppCell | nucseq-Epithelial-Epithelial_Neuro-Secretory-PNEC-PNEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.49e-05 | 171 | 54 | 4 | ed4fb6c84579d99df33de5f8f928c3cd2f3d3d72 | |
| ToppCell | nucseq-Epithelial-Epithelial_Neuro-Secretory|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.62e-05 | 172 | 54 | 4 | d0cdedd734406988a9a93d7300c7b1a8b4b45c38 | |
| ToppCell | CV-Mild-6|Mild / Virus stimulation, Condition and Cluster | 6.01e-05 | 175 | 54 | 4 | c4d530dbb37942427c9cd0a1533faeb6a3a45381 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_GRIP2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.01e-05 | 175 | 54 | 4 | 0c648e7f67ffbe3b476a2ca77d246554f8cd1882 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 6.14e-05 | 176 | 54 | 4 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.28e-05 | 177 | 54 | 4 | 8e4005fad50e6f919da175f3b9ae58849dbd60b1 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 6.42e-05 | 178 | 54 | 4 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.15e-05 | 183 | 54 | 4 | af14da45267261e775dd6dab7a4c359b181e46f1 | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.45e-05 | 185 | 54 | 4 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | 21-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 7.93e-05 | 188 | 54 | 4 | e78d4f7a5d28c77503cb041ff585d13df4c88bd2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 8.26e-05 | 190 | 54 | 4 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.26e-05 | 190 | 54 | 4 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 8.26e-05 | 190 | 54 | 4 | 842760bfe0a52e67bad800efa7d99448a4a23ebb | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.43e-05 | 191 | 54 | 4 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 8.43e-05 | 191 | 54 | 4 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 8.43e-05 | 191 | 54 | 4 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.43e-05 | 191 | 54 | 4 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | Control-NK_CD56bright|Control / Disease condition and Cell class | 8.78e-05 | 193 | 54 | 4 | 8b1e7a226a6057e1097c1525984127b54e823876 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.95e-05 | 194 | 54 | 4 | 920955e775617d6156c5ee8b90d2cecd01a70e12 | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 8.95e-05 | 194 | 54 | 4 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | control-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.13e-05 | 195 | 54 | 4 | 66959ae839eb60a573da06bdd227090ebb5bb9ed | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 9.13e-05 | 195 | 54 | 4 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 9.13e-05 | 195 | 54 | 4 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.69e-05 | 198 | 54 | 4 | 3550798bfb9a426f3b28538a9778159bec2480d0 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-05 | 198 | 54 | 4 | d6812494874be0c14361ac2ac3e418b335bb8f55 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-Immature_CPNs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.69e-05 | 198 | 54 | 4 | 4e598aab92141e7d32ec963291ddeed14a21beba | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.01e-04 | 200 | 54 | 4 | e79d93d55b25804f2608185168da472301b6ebca | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.01e-04 | 200 | 54 | 4 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-OPC_related-Oligodendrocyte/OPC|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.01e-04 | 200 | 54 | 4 | 7557ea33c3d080d0fa4ca0c2703279932d01e6d0 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.01e-04 | 200 | 54 | 4 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.01e-04 | 200 | 54 | 4 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.01e-04 | 200 | 54 | 4 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.01e-04 | 200 | 54 | 4 | 5ec469267747dce3601c1d8ad01af89fa5b29acc | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-04 | 200 | 54 | 4 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.01e-04 | 200 | 54 | 4 | d416a7be1a4e6232fb58a9687774da24821f1fdd | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.01e-04 | 200 | 54 | 4 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-OPC_related|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.01e-04 | 200 | 54 | 4 | 3dcaeb9f1e387784c299bfe0da1516598f82edf5 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.01e-04 | 200 | 54 | 4 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.01e-04 | 200 | 54 | 4 | 862db57d043bdf3cb059fbfc8b29bc1eafdf64ec | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.01e-04 | 200 | 54 | 4 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.01e-04 | 200 | 54 | 4 | a91345f268f13170c27309333603eb82400c9947 | |
| ToppCell | Neuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.01e-04 | 200 | 54 | 4 | 45ddc5ef2caa87ada88327b63ba9b150a6bb3aa5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.01e-04 | 200 | 54 | 4 | 320d5a3a1e7da2fa8f1a164e29e180ec8ac9889c | |
| ToppCell | Control|World / 5 Neutrophil clusters in COVID-19 patients | 3.40e-04 | 112 | 54 | 3 | b3e5a901f3dbd6e49e968dd2a371f68274951735 | |
| ToppCell | Control-Neu_0|World / 5 Neutrophil clusters in COVID-19 patients | 4.16e-04 | 120 | 54 | 3 | 840d0ac995e2fa41996514753e4e03c4aa4a26d0 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 4.36e-04 | 122 | 54 | 3 | 1ed865f0ecfe304fb86313ff51c04e9052357270 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.79e-04 | 126 | 54 | 3 | 730fc6dc740613b55e40e85334fa30330aa81c3b | |
| ToppCell | Control-Myeloid_G-Neutrophil|Control / Disease group, lineage and cell class | 4.90e-04 | 127 | 54 | 3 | d4af23d621b546785a077c367c3a66c59749fc15 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.02e-04 | 128 | 54 | 3 | 9b3c57d559a5ed8d590dd89b64a57a3227d8c684 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.02e-04 | 128 | 54 | 3 | 58639cfdc70ff6764adcc5c1ce9eba9d033b8209 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.13e-04 | 129 | 54 | 3 | 5578a9ef85706ab6a204ff31716e781ec3893b75 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.25e-04 | 130 | 54 | 3 | cd6d8d646345b01ff0f04f776330a05b82e63bc9 | |
| ToppCell | Control-Myeloid_G|Control / Disease group, lineage and cell class | 5.37e-04 | 131 | 54 | 3 | d5a53431f1f1b283fb9338b8561e6381f0227c62 | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 5.86e-04 | 135 | 54 | 3 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-Neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 5.99e-04 | 136 | 54 | 3 | b46450292e0cd549eb3bafdd3fed22f41d85bfbe | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-8|TCGA-Lung / Sample_Type by Project: Shred V9 | 6.12e-04 | 137 | 54 | 3 | 05ca83c30e3dbe74c81278b3636d57da2c20b458 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Itm2a|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.07e-04 | 144 | 54 | 3 | 0bbe670454846cf9bc7464ae4e91488415c4111d | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 7.50e-04 | 147 | 54 | 3 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.26e-04 | 152 | 54 | 3 | fed80b467ec9e30c7f98bed6cc4f8c583b715e9e | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.58e-04 | 154 | 54 | 3 | 692eb053620db86d301b09bf743ab45fccc245be | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-3|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.58e-04 | 154 | 54 | 3 | 923f5eb8e9258105dbdbe57a5e7976ef60dae29b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 8.74e-04 | 155 | 54 | 3 | 9d53caee196b5c2bbc90c4f54f693b64d4086065 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.91e-04 | 156 | 54 | 3 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.07e-04 | 157 | 54 | 3 | 1e3a4a7193d95f09d71c2dfe704b8e626c6d9624 | |
| ToppCell | droplet-Kidney-nan-18m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.07e-04 | 157 | 54 | 3 | eb64a4e89843895d16015c7d51805f164ed7ea5b | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.07e-04 | 157 | 54 | 3 | 516903469756c5fabfdf56d7bd59b3bdd7b44e39 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-04 | 158 | 54 | 3 | debebc8534a80e5500051f6fd352dc201585968d | |
| ToppCell | COPD-Epithelial-PNEC|COPD / Disease state, Lineage and Cell class | 9.41e-04 | 159 | 54 | 3 | 6018124980c55190928409f3bf41d846a118954a | |
| ToppCell | COPD-Epithelial-PNEC|World / Disease state, Lineage and Cell class | 9.58e-04 | 160 | 54 | 3 | cdea93317b0ebb801ddbe73bca6149ce2c727f16 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.58e-04 | 160 | 54 | 3 | 70f3637dd0bcfcef421aa114f946fff0048f192e | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.76e-04 | 161 | 54 | 3 | deb10628d258fb813c293f81fb71be8e383dc82a | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.76e-04 | 161 | 54 | 3 | 8aaca49b53a551395f4025ac4e535c7b0ce41a49 | |
| ToppCell | CD8+_Memory_T_cell-FLU-1|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 9.93e-04 | 162 | 54 | 3 | 76f39935763848ea6e7917b2f9f1432c543063d9 | |
| Computational | Neighborhood of CAMK4 | 5.64e-04 | 290 | 39 | 6 | MORF_CAMK4 | |
| Computational | Neighborhood of ARL3 | 7.23e-04 | 304 | 39 | 6 | MORF_ARL3 | |
| Computational | Neighborhood of ERCC4 | 9.61e-04 | 321 | 39 | 6 | MORF_ERCC4 | |
| Computational | Neighborhood of SUPT3H | 1.07e-03 | 328 | 39 | 6 | MORF_SUPT3H | |
| Computational | Neighborhood of ATF2 | 1.11e-03 | 330 | 39 | 6 | MORF_ATF2 | |
| Drug | glutamin | NCOA3 NCOR2 ATN1 FOXP2 ATXN1 GLG1 POLG CELF3 MAMLD1 ATXN3 KCNN3 IRF2BPL NFAT5 CREBBP AR RAI1 HTT TBP THAP11 | 1.89e-19 | 461 | 52 | 19 | CID000000738 |
| Drug | l-Alanyl-l-glutamine | 1.73e-09 | 150 | 52 | 8 | CID000123935 | |
| Drug | 2-cyanoacetamide | 8.29e-08 | 162 | 52 | 7 | CID000007898 | |
| Drug | 1 C2 | 1.07e-07 | 100 | 52 | 6 | CID005327152 | |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 2.83e-07 | 194 | 52 | 7 | 4246_DN | |
| Drug | levodopa/carbidopa | 3.48e-07 | 26 | 52 | 4 | CID000104778 | |
| Drug | CV-1 | 5.32e-07 | 213 | 52 | 7 | CID000130105 | |
| Drug | A25618 | NCOA3 NCOR2 TSC22D1 BRD4 ATXN3 RUNX2 CREBBP MEF2A AR MED12 TBP | 1.15e-06 | 777 | 52 | 11 | CID000005562 |
| Drug | Dihydrotestosterone | 1.48e-06 | 360 | 52 | 8 | ctd:D013196 | |
| Drug | alanine | 2.53e-06 | 269 | 52 | 7 | CID000000602 | |
| Drug | Androstenedione | 3.36e-06 | 45 | 52 | 4 | ctd:D000735 | |
| Drug | pirimicarb | 5.15e-06 | 50 | 52 | 4 | CID000031645 | |
| Drug | Alfadolone acetate [23930-37-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 5.52e-06 | 196 | 52 | 6 | 6506_DN | |
| Drug | Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; PC3; HT_HG-U133A | 5.52e-06 | 196 | 52 | 6 | 4227_DN | |
| Drug | Pinacidil [85371-64-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 5.85e-06 | 198 | 52 | 6 | 7437_DN | |
| Drug | AC1L2E0P | 6.02e-06 | 307 | 52 | 7 | CID000019390 | |
| Drug | Sotalol hydrochloride [959-24-0]; Down 200; 13uM; MCF7; HT_HG-U133A | 6.02e-06 | 199 | 52 | 6 | 7338_DN | |
| Drug | AC1NB8R3 | 8.88e-06 | 213 | 52 | 6 | CID004489307 | |
| Drug | 5'-pCAA-3' | 1.01e-05 | 126 | 52 | 5 | CID000482140 | |
| Drug | stanolone benzoate | 1.53e-05 | 3 | 52 | 2 | ctd:C040109 | |
| Drug | AC1ND2OB | 3.05e-05 | 265 | 52 | 6 | CID004568637 | |
| Drug | 9,10-dihydrophenanthrene | 3.06e-05 | 4 | 52 | 2 | CID000013058 | |
| Drug | dimethyl phthalate | 3.07e-05 | 714 | 52 | 9 | ctd:C024629 | |
| Drug | BW-B 70C; Up 200; 31.6uM; MCF7; HT_HG-U133A_EA | 4.16e-05 | 169 | 52 | 5 | 1132_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 4.28e-05 | 170 | 52 | 5 | 1050_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 4.53e-05 | 172 | 52 | 5 | 1072_DN | |
| Drug | neocarzinostatin chromophore | 4.86e-05 | 288 | 52 | 6 | CID000447545 | |
| Drug | xenon | 4.90e-05 | 88 | 52 | 4 | CID000023991 | |
| Drug | lithocholyltaurine | 4.91e-05 | 175 | 52 | 5 | CID000010595 | |
| Drug | HHCA | 5.09e-05 | 5 | 52 | 2 | CID009576894 | |
| Drug | phenothiazine | 5.09e-05 | 5 | 52 | 2 | ctd:C031637 | |
| Drug | ahz | 5.32e-05 | 32 | 52 | 3 | CID000656929 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 5.33e-05 | 178 | 52 | 5 | 1112_DN | |
| Drug | Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; PC3; HT_HG-U133A | 7.08e-05 | 189 | 52 | 5 | 4304_UP | |
| Drug | colcemid; Up 200; 11.7uM; MCF7; HT_HG-U133A_EA | 7.26e-05 | 190 | 52 | 5 | 1103_UP | |
| Drug | rottlerin; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 7.26e-05 | 190 | 52 | 5 | 914_UP | |
| Drug | Flunisolide [3385-03-3]; Up 200; 9.2uM; PC3; HT_HG-U133A | 7.63e-05 | 192 | 52 | 5 | 4303_UP | |
| Drug | butamben | 7.63e-05 | 6 | 52 | 2 | ctd:C004605 | |
| Drug | androstan-3-ol | 7.63e-05 | 6 | 52 | 2 | ctd:C000658 | |
| Drug | Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; PC3; HT_HG-U133A | 7.82e-05 | 193 | 52 | 5 | 3811_UP | |
| Drug | troglitazone; Down 200; 10uM; PC3; HG-U133A | 7.82e-05 | 193 | 52 | 5 | 431_DN | |
| Drug | Galanthamine hydrobromide [1953-04-4]; Down 200; 10.8uM; PC3; HT_HG-U133A | 7.82e-05 | 193 | 52 | 5 | 4186_DN | |
| Drug | vorinostat | 7.83e-05 | 314 | 52 | 6 | CID000005311 | |
| Drug | Benfotiamine [22457-89-2]; Up 200; 8.6uM; PC3; HT_HG-U133A | 8.21e-05 | 195 | 52 | 5 | 4312_UP | |
| Drug | Beclomethasone dipropionate [5534-09-8]; Up 200; 7.6uM; HL60; HT_HG-U133A | 8.21e-05 | 195 | 52 | 5 | 3001_UP | |
| Drug | Flumethasone [2135-17-3]; Up 200; 9.8uM; PC3; HT_HG-U133A | 8.21e-05 | 195 | 52 | 5 | 4272_UP | |
| Drug | Dehydrocholic acid [81-23-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 8.21e-05 | 195 | 52 | 5 | 1523_DN | |
| Drug | AC1L9FY1 | 8.39e-05 | 101 | 52 | 4 | CID000444218 | |
| Drug | Carbachol [51-83-2]; Up 200; 21.8uM; HL60; HT_HG-U133A | 8.41e-05 | 196 | 52 | 5 | 3042_UP | |
| Drug | 17-AAG; Down 200; 1uM; PC3; HG-U133A | 8.41e-05 | 196 | 52 | 5 | 432_DN | |
| Drug | Aceclofenac [89796-99-6]; Up 200; 11.2uM; PC3; HT_HG-U133A | 8.41e-05 | 196 | 52 | 5 | 7269_UP | |
| Drug | Hymecromone [90-33-5]; Down 200; 22.8uM; MCF7; HT_HG-U133A | 8.41e-05 | 196 | 52 | 5 | 3383_DN | |
| Drug | Acacetin [480-44-4]; Down 200; 14uM; PC3; HT_HG-U133A | 8.41e-05 | 196 | 52 | 5 | 3767_DN | |
| Drug | SB 202190; Up 200; 1uM; MCF7; HT_HG-U133A | 8.41e-05 | 196 | 52 | 5 | 7054_UP | |
| Drug | Sulpiride [15676-16-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 8.61e-05 | 197 | 52 | 5 | 1467_UP | |
| Drug | Cefazolin sodium salt [27164-46-1]; Up 200; 8.4uM; HL60; HT_HG-U133A | 8.61e-05 | 197 | 52 | 5 | 2564_UP | |
| Drug | E)-4-hydroxytamoxifen | 8.61e-05 | 197 | 52 | 5 | CID000063062 | |
| Drug | Medrysone [2668-66-8]; Up 200; 11.6uM; PC3; HT_HG-U133A | 8.61e-05 | 197 | 52 | 5 | 4266_UP | |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 8.61e-05 | 197 | 52 | 5 | 7201_DN | |
| Drug | Sulfamonomethoxine [1220-83-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 7200_DN | |
| Drug | Dapsone [80-08-0]; Down 200; 16.2uM; HL60; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 1868_DN | |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 7519_DN | |
| Drug | Isoxicam [34552-84-6]; Down 200; 12uM; HL60; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 1862_DN | |
| Drug | S H Y | 8.96e-05 | 38 | 52 | 3 | CID004369485 | |
| Drug | tamoxifen citrate; Up 200; 1uM; MCF7; HG-U133A | 9.03e-05 | 199 | 52 | 5 | 380_UP | |
| Drug | Cloxacillin sodium salt [642-78-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 9.03e-05 | 199 | 52 | 5 | 2289_DN | |
| Drug | Amiloride hydrochloride dihydrate [17440-83-4]; Down 200; 13.2uM; PC3; HG-U133A | 9.03e-05 | 199 | 52 | 5 | 1890_DN | |
| Drug | SC-58125; Up 200; 10uM; MCF7; HG-U133A | 9.03e-05 | 199 | 52 | 5 | 254_UP | |
| Drug | DNA-PK Inhibitor III; Down 200; 1uM; PC3; HT_HG-U133A | 9.03e-05 | 199 | 52 | 5 | 7518_DN | |
| Drug | Benoxinate hydrochloride [5987-82-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 9.25e-05 | 200 | 52 | 5 | 1476_DN | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 9.25e-05 | 200 | 52 | 5 | 2323_DN | |
| Drug | Succimer | TSC22D1 ATXN1 PHLDA1 GLG1 ZMYND8 ATXN3 SIK3 RUNX2 NFAT5 CREBBP MEF2A | 1.09e-04 | 1264 | 52 | 11 | ctd:D004113 |
| Drug | NSC-364372 | 1.10e-04 | 484 | 52 | 7 | CID000435143 | |
| Drug | DB07328 | 1.11e-04 | 208 | 52 | 5 | CID011840913 | |
| Drug | AC1L3UEY | 1.30e-04 | 113 | 52 | 4 | CID000122342 | |
| Drug | fluorosilicate | 1.42e-04 | 8 | 52 | 2 | CID000028117 | |
| Drug | Magnetite Nanoparticles | TSC22D1 ATXN1 PHLDA1 GLG1 ZMYND8 ATXN3 SIK3 RUNX2 NFAT5 CREBBP MEF2A | 1.49e-04 | 1310 | 52 | 11 | ctd:D058185 |
| Drug | 17-alpha-Hydroxyprogesterone | 1.82e-04 | 9 | 52 | 2 | ctd:D019326 | |
| Drug | FPCA | 1.82e-04 | 9 | 52 | 2 | CID000131272 | |
| Drug | Dronabinol | 1.88e-04 | 905 | 52 | 9 | ctd:D013759 | |
| Drug | Spotlight | 1.97e-04 | 126 | 52 | 4 | CID000086222 | |
| Drug | dansylamide | 2.03e-04 | 127 | 52 | 4 | CID000065077 | |
| Drug | AC1L71LN | 2.09e-04 | 128 | 52 | 4 | CID000327966 | |
| Drug | AC1LA6KT | 2.17e-04 | 51 | 52 | 3 | CID000508110 | |
| Drug | AC1L2FXT | 2.28e-04 | 10 | 52 | 2 | CID000071316 | |
| Drug | DMAB | 2.42e-04 | 133 | 52 | 4 | CID000006053 | |
| Drug | Mifepristone | 2.49e-04 | 553 | 52 | 7 | ctd:D015735 | |
| Drug | tris(chloroethyl)phosphate | 2.71e-04 | 55 | 52 | 3 | ctd:C031324 | |
| Drug | quercetagetin | 2.78e-04 | 11 | 52 | 2 | CID005281680 | |
| Drug | NSC71948 | 2.79e-04 | 138 | 52 | 4 | CID000415676 | |
| Drug | AC1L2XIZ | 3.33e-04 | 12 | 52 | 2 | CID000104803 | |
| Drug | AC1O4QJG | 3.51e-04 | 60 | 52 | 3 | CID006398504 | |
| Drug | chrysamine | 4.24e-04 | 64 | 52 | 3 | CID006011258 | |
| Drug | Asbestos, Crocidolite | NCOA3 TSC22D1 ARID1B PHLDA1 MAML2 SIK3 RUNX2 NFAT5 MAML3 MED12 | 4.34e-04 | 1241 | 52 | 10 | ctd:D017638 |
| Drug | Azaguanine-8 [134-58-7]; Up 200; 26.2uM; HL60; HT_HG-U133A | 4.78e-04 | 159 | 52 | 4 | 1833_UP | |
| Drug | vitamin E | 4.89e-04 | 441 | 52 | 6 | CID000002116 | |
| Drug | dicyclohexyl phthalate | 5.74e-04 | 836 | 52 | 8 | ctd:C036042 | |
| Drug | Bortezomib | 5.83e-04 | 838 | 52 | 8 | ctd:D000069286 | |
| Drug | Colchicine [64-86-8]; Up 200; 10uM; HL60; HG-U133A | 6.28e-04 | 171 | 52 | 4 | 1598_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 6.56e-04 | 173 | 52 | 4 | 4237_DN | |
| Disease | schizophrenia (is_implicated_in) | 3.24e-07 | 78 | 54 | 5 | DOID:5419 (is_implicated_in) | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.47e-06 | 447 | 54 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | testosterone measurement | MAGI1 NCOR2 NCOA6 ARID1B NALF1 ASCL1 FAM157A ZFHX3 MIDEAS AR MED12 RAI1 | 2.56e-06 | 1275 | 54 | 12 | EFO_0004908 |
| Disease | Paroxysmal atrial fibrillation | 9.94e-06 | 156 | 54 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 9.94e-06 | 156 | 54 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 9.94e-06 | 156 | 54 | 5 | C2585653 | |
| Disease | Atrial Fibrillation | 1.12e-05 | 160 | 54 | 5 | C0004238 | |
| Disease | Breast Neoplasms, Male | 1.97e-05 | 4 | 54 | 2 | C0242788 | |
| Disease | Carcinoma of Male Breast | 1.97e-05 | 4 | 54 | 2 | C0238033 | |
| Disease | Phyllodes Tumor | 3.28e-05 | 5 | 54 | 2 | C0010701 | |
| Disease | Malignant Cystosarcoma Phyllodes | 3.28e-05 | 5 | 54 | 2 | C0600066 | |
| Disease | Adenoid Cystic Carcinoma | 3.45e-05 | 100 | 54 | 4 | C0010606 | |
| Disease | vital capacity | NCOA3 NCOR2 NCOA6 BRD4 ATXN3 FAM157B ZFHX3 RUNX2 ZNF853 NFAT5 | 7.14e-05 | 1236 | 54 | 10 | EFO_0004312 |
| Disease | hematocrit | 8.35e-05 | 1011 | 54 | 9 | EFO_0004348 | |
| Disease | hypospadias (is_implicated_in) | 9.14e-05 | 8 | 54 | 2 | DOID:10892 (is_implicated_in) | |
| Disease | Male sterility | 9.45e-05 | 48 | 54 | 3 | C0917731 | |
| Disease | Male infertility | 9.45e-05 | 48 | 54 | 3 | C0021364 | |
| Disease | Subfertility, Male | 9.45e-05 | 48 | 54 | 3 | C0848676 | |
| Disease | Malignant tumor of prostate | 1.17e-04 | 9 | 54 | 2 | cv:C0376358 | |
| Disease | Abnormality of the face | 1.17e-04 | 9 | 54 | 2 | C4025871 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.24e-04 | 139 | 54 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | Prostatic Neoplasms | 1.26e-04 | 616 | 54 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.26e-04 | 616 | 54 | 7 | C0376358 | |
| Disease | Huntington's disease (is_marker_for) | 1.27e-04 | 53 | 54 | 3 | DOID:12858 (is_marker_for) | |
| Disease | neuroimaging measurement | 1.27e-04 | 1069 | 54 | 9 | EFO_0004346 | |
| Disease | Parkinson disease, late-onset | 1.47e-04 | 10 | 54 | 2 | cv:C3160718 | |
| Disease | PARKINSON DISEASE, LATE-ONSET | 1.47e-04 | 10 | 54 | 2 | 168600 | |
| Disease | Intellectual Disability | 1.63e-04 | 447 | 54 | 6 | C3714756 | |
| Disease | polybrominated biphenyl measurement, gestational serum measurement, fetal genotype effect measurement, polybrominated diphenyl ether measurement | 1.79e-04 | 11 | 54 | 2 | EFO_0007959, EFO_0007961, EFO_0007962, EFO_0007964 | |
| Disease | Schizophrenia | 1.92e-04 | 883 | 54 | 8 | C0036341 | |
| Disease | breast carcinoma (is_marker_for) | 2.44e-04 | 66 | 54 | 3 | DOID:3459 (is_marker_for) | |
| Disease | cardioembolic stroke | 2.69e-04 | 170 | 54 | 4 | EFO_1001976 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 2.79e-04 | 69 | 54 | 3 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | sulfate measurement | 2.95e-04 | 14 | 54 | 2 | EFO_0007864 | |
| Disease | Lymphoma, Large-Cell, Follicular | 3.40e-04 | 15 | 54 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 3.40e-04 | 15 | 54 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 3.40e-04 | 15 | 54 | 2 | C0079758 | |
| Disease | Alopecia, Male Pattern | 3.40e-04 | 15 | 54 | 2 | C4083212 | |
| Disease | Androgenetic Alopecia | 3.40e-04 | 15 | 54 | 2 | C0162311 | |
| Disease | Lymphoma, Follicular, Grade 2 | 3.40e-04 | 15 | 54 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 3.40e-04 | 15 | 54 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 3.40e-04 | 15 | 54 | 2 | C1956130 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 3.40e-04 | 15 | 54 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | Female pattern alopecia (disorder) | 3.40e-04 | 15 | 54 | 2 | C0263477 | |
| Disease | major depressive disorder (is_implicated_in) | 4.39e-04 | 17 | 54 | 2 | DOID:1470 (is_implicated_in) | |
| Disease | Breast Carcinoma | 4.40e-04 | 538 | 54 | 6 | C0678222 | |
| Disease | Feeding difficulties | 4.94e-04 | 18 | 54 | 2 | C0232466 | |
| Disease | breast carcinoma | 5.00e-04 | 1019 | 54 | 8 | EFO_0000305 | |
| Disease | acute lymphoblastic leukemia, response to antineoplastic agent | 5.51e-04 | 19 | 54 | 2 | EFO_0000220, GO_0097327 | |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 5.51e-04 | 19 | 54 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 | |
| Disease | Pseudopelade | 5.51e-04 | 19 | 54 | 2 | C0086873 | |
| Disease | Alopecia | 5.51e-04 | 19 | 54 | 2 | C0002170 | |
| Disease | diet measurement, HOMA-B | 5.51e-04 | 19 | 54 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | forced expiratory volume | 5.65e-04 | 789 | 54 | 7 | EFO_0004314 | |
| Disease | lobe attachment | 5.65e-04 | 207 | 54 | 4 | EFO_0007667 | |
| Disease | diet measurement | 6.05e-04 | 1049 | 54 | 8 | EFO_0008111 | |
| Disease | Craniosynostosis | 6.12e-04 | 20 | 54 | 2 | C0010278 | |
| Disease | Lymphoma, Follicular | 6.12e-04 | 20 | 54 | 2 | C0024301 | |
| Disease | attention deficit hyperactivity disorder (is_implicated_in) | 6.12e-04 | 20 | 54 | 2 | DOID:1094 (is_implicated_in) | |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 6.75e-04 | 21 | 54 | 2 | EFO_0004616, EFO_0010726, EFO_1000786 | |
| Disease | Malignant neoplasm of breast | 7.06e-04 | 1074 | 54 | 8 | C0006142 | |
| Disease | Parkinson disease | 7.42e-04 | 22 | 54 | 2 | cv:C0030567 | |
| Disease | frailty measurement | 8.11e-04 | 23 | 54 | 2 | EFO_0009885 | |
| Disease | Neoplasm of the genitourinary tract | 8.84e-04 | 24 | 54 | 2 | cv:C0042065 | |
| Disease | Cerebral Astrocytoma | 9.60e-04 | 25 | 54 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 9.60e-04 | 25 | 54 | 2 | C0750936 | |
| Disease | Pilocytic Astrocytoma | 9.60e-04 | 25 | 54 | 2 | C0334583 | |
| Disease | Astrocytoma | 9.60e-04 | 25 | 54 | 2 | C0004114 | |
| Disease | Juvenile Pilocytic Astrocytoma | 9.60e-04 | 25 | 54 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 9.60e-04 | 25 | 54 | 2 | C0280785 | |
| Disease | Grade I Astrocytoma | 9.60e-04 | 25 | 54 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 9.60e-04 | 25 | 54 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 9.60e-04 | 25 | 54 | 2 | C0547065 | |
| Disease | Childhood Cerebral Astrocytoma | 9.60e-04 | 25 | 54 | 2 | C0338070 | |
| Disease | Gemistocytic astrocytoma | 1.04e-03 | 26 | 54 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 1.04e-03 | 26 | 54 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 1.04e-03 | 26 | 54 | 2 | C0334582 | |
| Disease | Sezary Syndrome | 1.12e-03 | 27 | 54 | 2 | C0036920 | |
| Disease | Anaplastic astrocytoma | 1.12e-03 | 27 | 54 | 2 | C0334579 | |
| Disease | Mental Depression | 1.21e-03 | 254 | 54 | 4 | C0011570 | |
| Disease | longevity, healthspan, parental longevity | 1.29e-03 | 29 | 54 | 2 | EFO_0004300, EFO_0007796, EFO_0009762 | |
| Disease | total blood protein measurement | 1.37e-03 | 449 | 54 | 5 | EFO_0004536 | |
| Disease | Hirschsprung Disease | 1.48e-03 | 31 | 54 | 2 | C0019569 | |
| Disease | waist-hip ratio | 1.65e-03 | 1226 | 54 | 8 | EFO_0004343 | |
| Disease | FEV/FEC ratio | 1.67e-03 | 1228 | 54 | 8 | EFO_0004713 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QQQQQQQQQQQQQRE | 361 | Q5SZQ8 | |
| FYQQQQQQQQQQQQQ | 531 | Q2M2I8 | |
| QQQQQQQQQQQLATA | 536 | Q2M2I8 | |
| QQQQRQEQQQQQQQQ | 1286 | O60885 | |
| HHHQQQQQQQQQQQQ | 481 | P54259 | |
| QQQQQQQQQQQQHHG | 491 | P54259 | |
| QLLQQQQQQQQQQQQ | 2196 | Q92793 | |
| QQQQQQQQQQQGSAG | 2206 | Q92793 | |
| QQLNQFQQQQQQQQQ | 191 | Q8NFD5 | |
| QQQQQQQQQHPISNN | 206 | Q8NFD5 | |
| EQQQQQQQQQQQQHQ | 196 | P54253 | |
| QQQQQQQQHQHQQQQ | 201 | P54253 | |
| QQQHQHQQQQQQQQQ | 206 | P54253 | |
| QQQQQQQQQQQAASV | 436 | Q9Y6R0 | |
| YDQQQQQQQQQQQQQ | 276 | Q7Z5J4 | |
| QQQQQQQQQQQALQS | 281 | Q7Z5J4 | |
| LQQQQQAQQQQQQHP | 401 | Q6ZW49 | |
| GKSQQQQQQQQQQQQ | 491 | Q9Y618 | |
| QQQLLIQQQQQQQQQ | 211 | O14910 | |
| IQQQQQQQQQQTQQN | 216 | O14910 | |
| QQQQQQQQQQQTEEW | 411 | Q96QZ7 | |
| QQQQQQQQQQHSNQT | 501 | Q96JK9 | |
| YIQQQQQQQQQQQQQ | 631 | Q96JK9 | |
| KQQQKQQQQQQQQQQ | 291 | P54252 | |
| AAQQQQQQQQQQQQQ | 101 | Q9H1B7 | |
| QQQQQQQQQQQQLNH | 116 | Q9H1B7 | |
| IYKNWQQQQQQQQQQ | 66 | C9JC47 | |
| SGDEQQQQQQQQQQQ | 26 | Q9UGI6 | |
| QAKEQQQQQQQQQQL | 196 | O15409 | |
| QQQQQQQQQLAAQQL | 201 | O15409 | |
| RRQQQQQQQQQQQQQ | 41 | P54098 | |
| RRQQQQQQQQQQQQQ | 71 | P0CG43 | |
| QQQQQQQQQQQQQLD | 76 | P0CG43 | |
| QQQQQQQQFQQQQQA | 161 | Q96RN5 | |
| QQQFQQQQQAALQQQ | 166 | Q96RN5 | |
| QQQQAALQQQQQQQQ | 171 | Q96RN5 | |
| ALQQQQQQQQQQQFQ | 176 | Q96RN5 | |
| QQQQQQQQFQAQQSA | 181 | Q96RN5 | |
| QAVVQQQQQLQQQQQ | 201 | Q96RN5 | |
| QQQQLQQQQQQQQHL | 206 | Q96RN5 | |
| QQQQQQQQQQQQALQ | 251 | Q96RN5 | |
| QQQQQHQQQQQQQAA | 2111 | Q93074 | |
| LLQQQQQQQQQQQQQ | 56 | P10275 | |
| PSGFQQQQQQQQQQQ | 416 | Q02078 | |
| PSQEQQQQQQQQQQQ | 1246 | O94916 | |
| YTQQQQQQQQQQQQQ | 586 | Q8IZL2 | |
| ISAQQQQQQQQQQQQ | 636 | Q8IZL2 | |
| NFPQLQQQQQQQQQQ | 256 | Q14686 | |
| QLQQQQQQQQQQQQP | 71 | Q92896 | |
| QRRQQQQQQQQQQQQ | 71 | P0CG42 | |
| SFQQQQQQQQQQQQQ | 16 | P42858 | |
| AAQSAQQQQQQQQQQ | 46 | P50553 | |
| QQQQQQQQQQQQAPQ | 51 | P50553 | |
| RNLNQQQQQQQQQQQ | 1746 | Q5JV73 | |
| QQQQQQQQQQQVAAA | 1766 | Q5JV73 | |
| SQQQQQQQQQQQANV | 491 | Q13495 | |
| QKQQQQQQPQQQQQQ | 246 | Q6PJG2 | |
| QQQPQQQQQQQQAAL | 251 | Q6PJG2 | |
| QQQQQQQQQQEQVSA | 901 | O75064 | |
| KMQRQQQQQQQQNQQ | 836 | Q9ULU4 | |
| QQQQQQQNQQQQPQS | 841 | Q9ULU4 | |
| LIQQQQQQQQQQQQQ | 41 | Q6P995 | |
| QQQQQQQQQQQKQLE | 46 | Q6P995 | |
| QQQQQQQLQKQQQQQ | 481 | Q8N4C8 | |
| SLQQQQQQQQQQQQQ | 521 | Q10571 | |
| QQQQQQQQQQRQNAA | 541 | Q10571 | |
| VAAQQQQQQQQQQQQ | 46 | Q13950 | |
| QQQQQQQQQQQEAAA | 61 | Q13950 | |
| QQQQQQQQQQQTQAF | 1266 | Q9Y6Q9 | |
| QQRQQQQQQQQQQEY | 1001 | Q9Y2K2 | |
| VQQQQQQQQQQQQQP | 496 | Q15714 | |
| QLQHQQQQQQQQQQQ | 186 | Q8WV24 | |
| QQQQQQQQQQAVAAA | 86 | P20226 | |
| LQLAQQQQQQQQQQQ | 421 | P78364 | |
| QQQQQQQQQQQQQAG | 1466 | Q68DE3 | |
| HQMQLQQQQQQQQQQ | 441 | O15405 | |
| QQQQQHLQQQINQQQ | 491 | O15405 | |
| QQFQQQQEQLQQQQQ | 226 | P0CG23 | |
| QQQQQQQQQQQQSSP | 121 | Q96EK4 | |
| SRQQQQQQQQQQQQQ | 1721 | Q15911 | |
| QQQQQQQQQQQAQTL | 1731 | Q15911 | |
| RNKQQQQQQQQQQQQ | 3596 | O14686 | |
| QQQQQQQQQQQQHSA | 3601 | O14686 | |
| AQKLQQQQQQQQQQQ | 3731 | O14686 | |
| QQQQQQQQQQHLLGQ | 3736 | O14686 | |
| QQQQQLQQQQQLQQQ | 3901 | O14686 | |
| QLQQQQQQQLQQQQQ | 3911 | O14686 | |
| QQQQLQQQQQLQQQQ | 3916 | O14686 | |
| QQQQQLQQQQLQQQQ | 3921 | O14686 | |
| LQQQQQQQQLQQQQQ | 3931 | O14686 | |
| QQQQLQQQQQQQLQQ | 3936 | O14686 | |
| QQQQQQQLQQQQQQL | 3941 | O14686 | |
| QQLQQQQQQLQQQQQ | 3946 | O14686 | |
| QQQQQFQQQQQQQQM | 3961 | O14686 | |
| EHQQQQRQQQQQQQQ | 71 | B1AL88 | |
| QQQQQQRQRQQQQQQ | 81 | B1AL88 |